<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38500880</PMID><DateCompleted><Year>2024</Year><Month>03</Month><Day>20</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>04</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>The knowns and unknowns of long COVID-19: from mechanisms to therapeutical approaches.</ArticleTitle><Pagination><StartPage>1344086</StartPage><MedlinePgn>1344086</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1344086</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2024.1344086</ELocationID><Abstract><AbstractText>The coronavirus disease 2019 (COVID-19) pandemic caused by SARS-CoV-2 has been defined as the greatest global health and socioeconomic crisis of modern times. While most people recover after being infected with the virus, a significant proportion of them continue to experience health issues weeks, months and even years after acute infection with SARS-CoV-2. This persistence of clinical symptoms in infected individuals for at least three months after the onset of the disease or the emergence of new symptoms lasting more than two months, without any other explanation and alternative diagnosis have been named long COVID, long-haul COVID, post-COVID-19 conditions, chronic COVID, or post-acute sequelae of SARS-CoV-2 (PASC). Long COVID has been characterized as a constellation of symptoms and disorders that vary widely in their manifestations. Further, the mechanisms underlying long COVID are not fully understood, which hamper efficient treatment options. This review describes predictors and the most common symptoms related to long COVID's effects on the central and peripheral nervous system and other organs and tissues. Furthermore, the transcriptional markers, molecular signaling pathways and risk factors for long COVID, such as sex, age, pre-existing condition, hospitalization during acute phase of COVID-19, vaccination, and lifestyle are presented. Finally, recommendations for patient rehabilitation and disease management, as well as alternative therapeutical approaches to long COVID sequelae are discussed. Understanding the complexity of this disease, its symptoms across multiple organ systems and overlapping pathologies and its possible mechanisms are paramount in developing diagnostic tools and treatments.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Gheorghita, Soldanescu, Lobiuc, Caliman Sturdza, Filip, Constantinescu &#x2013; Bercu, Dimian, Mangul and Covasa.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gheorghita</LastName><ForeName>Roxana</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Victor Babes University of Medicine and Pharmacy, Timisoara, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Sciences, College of Medicine and Biological Science, University of Suceava, Suceava, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soldanescu</LastName><ForeName>Iuliana</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Integrated Center for Research, Development and Innovation for Advanced Materials, Nanotechnologies, Manufacturing and Control Distributed Systems (MANSiD), University of Suceava, Suceava, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lobiuc</LastName><ForeName>Andrei</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, College of Medicine and Biological Science, University of Suceava, Suceava, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caliman Sturdza</LastName><ForeName>Olga Adriana</ForeName><Initials>OA</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, College of Medicine and Biological Science, University of Suceava, Suceava, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Suceava Emergency Clinical County Hospital, Suceava, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Filip</LastName><ForeName>Roxana</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, College of Medicine and Biological Science, University of Suceava, Suceava, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Suceava Emergency Clinical County Hospital, Suceava, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Constantinescu-Bercu</LastName><ForeName>Adela</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, College of Medicine and Biological Science, University of Suceava, Suceava, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Cardiovascular Science, Hemostasis Research Unit, University College London (UCL), London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dimian</LastName><ForeName>Mihai</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Integrated Center for Research, Development and Innovation for Advanced Materials, Nanotechnologies, Manufacturing and Control Distributed Systems (MANSiD), University of Suceava, Suceava, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Computer, Electronics and Automation, University of Suceava, Suceava, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mangul</LastName><ForeName>Serghei</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Clinical Pharmacy, USC Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, University of Southern California, Los Angeles, CA, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Quantitative and Computational Biology, USC Dornsife College of Letters, Arts and Sciences, University of Southern California (USC), Los Angeles, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Covasa</LastName><ForeName>Mihai</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, College of Medicine and Biological Science, University of Suceava, Suceava, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Basic Medical Sciences, Western University of Health Sciences, College of Osteopathic Medicine, Pomona, CA, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016420">Comment</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>03</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentOn"><RefSource>Sci Rep. 2022 Apr 11;12(1):6039. doi: 10.1038/s41598-022-10051-z</RefSource><PMID Version="1">35411017</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019468" MajorTopicYN="N">Disease Management</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Inflammatory markers</Keyword><Keyword MajorTopicYN="N">PASC</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">brain fog</Keyword><Keyword MajorTopicYN="N">vascular injury</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>2</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>3</Month><Day>20</Day><Hour>6</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>19</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>19</Day><Hour>3</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38500880</ArticleId><ArticleId IdType="pmc">PMC10944866</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2024.1344086</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>
WHO Coronavirus (COVID-19) Dashboard | WHO Coronavirus (COVID-19) Dashboard with Vaccination Data. Available online at: https://covid19.who.int/ (Accessed Jul. 29, 2023).</Citation></Reference><Reference><Citation>Sugiyama A, Miwata K, Kitahara Y, Okimoto M, Abe K, Bunthen E, et al. . Long COVID occurrence in COVID-19 survivors. Sci Rep. (2022) 12. doi:&#xa0;10.1038/s41598-022-10051-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-10051-z</ArticleId><ArticleId IdType="pmc">PMC8996498</ArticleId><ArticleId IdType="pubmed">35411017</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez-Sanchez I, Rodriguez-Ma&#xf1;as L, Laosa O. Long COVID-19: the need for an interdisciplinary approach. Clin Geriatr Med. (2022) 38:533&#x2013;44. doi:&#xa0;10.1016/J.CGER.2022.03.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.CGER.2022.03.005</ArticleId><ArticleId IdType="pmc">PMC8934714</ArticleId><ArticleId IdType="pubmed">35868671</ArticleId></ArticleIdList></Reference><Reference><Citation>
Post COVID-19 condition (Long COVID). Available online at: https://www.who.int/europe/news-room/fact-sheets/item/post-covid-19-condition (Accessed Jul. 29, 2023).</Citation></Reference><Reference><Citation>Nittas V, Gao M, West E, Ballouz T, Menges D, Hanson SW, et al. . Long COVID through a public health lens: an umbrella review. Public Health Rev. (2022) 43:1&#x2013;10. doi:&#xa0;10.3389/PHRS.2022.1604501</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/PHRS.2022.1604501</ArticleId><ArticleId IdType="pmc">PMC8963488</ArticleId><ArticleId IdType="pubmed">35359614</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkatesan P. NICE guideline on long COVID. Lancet Respir Med. (2021) 9:129. doi:&#xa0;10.1016/S2213-2600(21)00031-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00031-X</ArticleId><ArticleId IdType="pmc">PMC7832375</ArticleId><ArticleId IdType="pubmed">33453162</ArticleId></ArticleIdList></Reference><Reference><Citation>Raveendran AV. Long COVID-19: Challenges in the diagnosis and proposed diagnostic criteria. Diabetes Metab Syndrome: Clin Res Rev. (2021) 15:145&#x2013;6. doi:&#xa0;10.1016/J.DSX.2020.12.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.DSX.2020.12.025</ArticleId><ArticleId IdType="pmc">PMC7737559</ArticleId><ArticleId IdType="pubmed">33341598</ArticleId></ArticleIdList></Reference><Reference><Citation>Mantovani A, Concetta Morrone M, Patrono C, Santoro MG, Schiaffino S, Remuzzi G, et al. . Long Covid: where we stand and challenges ahead. Cell Death Differ. (2022) 29:1891&#x2013;900. doi:&#xa0;10.1038/S41418-022-01052-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/S41418-022-01052-6</ArticleId><ArticleId IdType="pmc">PMC9449925</ArticleId><ArticleId IdType="pubmed">36071155</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. (2023) 21:133&#x2013;46. doi:&#xa0;10.1038/S41579-022-00846-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/S41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Rando HM, Bennett TD, Byrd JB, Bramante C, Callahan TJ, Chute CG, et al. . Challenges in defining Long COVID: Striking differences across literature, Electronic Health Records, and patient-reported information. medRxiv. (2021). doi:&#xa0;10.1101/2021.03.20.21253896</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.03.20.21253896</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-De-las-pe&#xf1;as C, Palacios-Ce&#xf1;a D, G&#xf3;mez-Mayordomo V, Cuadrado&#xa0; ML, Florencio LL. Defining post-COVID symptoms (Post-acute COVID, long COVID, persistent post-COVID): an integrative classification. Int J Environ Res Public Health. (2021) 18:1&#x2013;9. doi:&#xa0;10.3390/IJERPH18052621</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/IJERPH18052621</ArticleId><ArticleId IdType="pmc">PMC7967389</ArticleId><ArticleId IdType="pubmed">33807869</ArticleId></ArticleIdList></Reference><Reference><Citation>Khazaal S, Harb J, Rima M, Annweiler C, Wu Y, Cao Z, et al. . The pathophysiology of long COVID throughout the renin-angiotensin system. Molecules. (2022) 27(9):2903. doi:&#xa0;10.3390/MOLECULES27092903</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/MOLECULES27092903</ArticleId><ArticleId IdType="pmc">PMC9101946</ArticleId><ArticleId IdType="pubmed">35566253</ArticleId></ArticleIdList></Reference><Reference><Citation>Blomberg B, Greve-Isdahl Mohn K, Brokstad KA, Zhou F, Linchausen DW, Hansen BA, et al. . Long COVID in a prospective cohort of home-isolated patients. Nat&#xa0;Med. (2021) 27:1607&#x2013;13. doi:&#xa0;10.1038/S41591-021-01433-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/S41591-021-01433-3</ArticleId><ArticleId IdType="pmc">PMC8440190</ArticleId><ArticleId IdType="pubmed">34163090</ArticleId></ArticleIdList></Reference><Reference><Citation>Byrne EA. Understanding Long Covid: Nosology, social attitudes and stigma. Brain Behav Immun. (2022) 99:17&#x2013;24. doi:&#xa0;10.1016/J.BBI.2021.09.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.BBI.2021.09.012</ArticleId><ArticleId IdType="pubmed">34563621</ArticleId></ArticleIdList></Reference><Reference><Citation>Vernon SD, Hartle M, Sullivan K, Bell J, Abbaszadeh S, Unutmaz D, et al. . Post-exertional malaise among people with long COVID compared to myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Work. (2023) 74:1179&#x2013;86. doi:&#xa0;10.3233/WOR-220581</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/WOR-220581</ArticleId><ArticleId IdType="pubmed">36911963</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong TL, Weitzer DJ. Long COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)-A systemic review and comparison of clinical presentation and symptomatology. Med (Kaunas). (2021) 57(5):418. doi:&#xa0;10.3390/MEDICINA57050418</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/MEDICINA57050418</ArticleId><ArticleId IdType="pmc">PMC8145228</ArticleId><ArticleId IdType="pubmed">33925784</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Dercon Q, Luciano S, Geddes JR, Husain M, Harrison PJ. Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19. PloS Med. (2021) 18:e1003773. doi:&#xa0;10.1371/JOURNAL.PMED.1003773</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/JOURNAL.PMED.1003773</ArticleId><ArticleId IdType="pmc">PMC8478214</ArticleId><ArticleId IdType="pubmed">34582441</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xd8;stergaard L. SARS CoV-2 related microvascular damage and symptoms during and after COVID-19: Consequences of capillary transit-time changes, tissue hypoxia and inflammation. Physiol Rep. (2021) 9(3):e14726. doi:&#xa0;10.14814/PHY2.14726</Citation><ArticleIdList><ArticleId IdType="doi">10.14814/PHY2.14726</ArticleId><ArticleId IdType="pmc">PMC7849453</ArticleId><ArticleId IdType="pubmed">33523608</ArticleId></ArticleIdList></Reference><Reference><Citation>de Miranda DA, Gomes S, Filgueiras PS, Corsini CA, Almeida NB, Silva RA, et al. . Long COVID-19 syndrome: a 14-months longitudinal study during the two first epidemic peaks in Southeast Brazil. Trans R Soc Trop Med Hyg. (2022) 116:1007&#x2013;14. doi:&#xa0;10.1093/TRSTMH/TRAC030</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/TRSTMH/TRAC030</ArticleId><ArticleId IdType="pubmed">35514142</ArticleId></ArticleIdList></Reference><Reference><Citation>Roth PH, Gadebusch-Bondio M. The contested meaning of &#x2018;long COVID&#x2019; - Patients, doctors, and the politics of subjective evidence. Soc Sci Med. (2022) 292:1&#x2013;8. doi:&#xa0;10.1016/J.SOCSCIMED.2021.114619</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.SOCSCIMED.2021.114619</ArticleId><ArticleId IdType="pmc">PMC8629766</ArticleId><ArticleId IdType="pubmed">34906823</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziauddeen N, Gurdasani D, O&#x2019;Hara ME, Hastie C, Roderick P, Yao G, et al. . Characteristics and impact of Long Covid: Findings from an online survey. PloS One. (2022) 17(3):e0264331. doi:&#xa0;10.1371/JOURNAL.PONE.0264331</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/JOURNAL.PONE.0264331</ArticleId><ArticleId IdType="pmc">PMC8903286</ArticleId><ArticleId IdType="pubmed">35259179</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan Sui Ko A, Candellier A, Mercier M, Joseph C, Schmit JL, Lanoix JP, et al. . Number of initial symptoms is more related to long COVID-19 than acute severity of infection: a prospective cohort of hospitalized patients. Int J Infect Dis. (2022) 118:220&#x2013;3. doi:&#xa0;10.1016/J.IJID.2022.03.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.IJID.2022.03.006</ArticleId><ArticleId IdType="pmc">PMC8896858</ArticleId><ArticleId IdType="pubmed">35257903</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendelson M, Nel J, Blumberg L, Madhi SA, Dryden M, Stevens W, et al. . Long-COVID: An evolving problem with an extensive impact. South Afr Med J. (2020) 111:10&#x2013;2. doi:&#xa0;10.7196/SAMJ.2020.V111I11.15433</Citation><ArticleIdList><ArticleId IdType="doi">10.7196/SAMJ.2020.V111I11.15433</ArticleId><ArticleId IdType="pubmed">33403997</ArticleId></ArticleIdList></Reference><Reference><Citation>Kostka K, Roel E, Trinh NTH, Mercad&#xe9;-Besora N, Delmestri A, Mateu L, et al. . The burden of post-acute COVID-19 symptoms in a multinational network cohort analysis. Nat Commun. (2023) 14:7449. doi:&#xa0;10.1038/s41467-023-42726-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-42726-0</ArticleId><ArticleId IdType="pmc">PMC10656441</ArticleId><ArticleId IdType="pubmed">37978296</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogarty H, Townsend L, Morrin H, Ahmad A, Comerford C, Karampini E, et al. . Persistent endotheliopathy in the pathogenesis of long COVID syndrome. J Thromb Haemost. (2021) 19:2546&#x2013;53. doi:&#xa0;10.1111/JTH.15490</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/JTH.15490</ArticleId><ArticleId IdType="pmc">PMC8420256</ArticleId><ArticleId IdType="pubmed">34375505</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L, Fogarty H, Dyer A, Martin-Loeches I, Bannan C, Nadarajan P, et al. . Prolonged elevation of D-dimer levels in convalescent COVID-19 patients is independent of the acute phase response. J Thromb Haemost. (2021) 19:1064&#x2013;70. doi:&#xa0;10.1111/JTH.15267</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/JTH.15267</ArticleId><ArticleId IdType="pmc">PMC8013297</ArticleId><ArticleId IdType="pubmed">33587810</ArticleId></ArticleIdList></Reference><Reference><Citation>Constantinescu-Bercu A, Kessler A, de Groot R, Dragunaite B, Heightman M, Hillman T, et al. . Analysis of thrombogenicity under flow reveals new insights into the prothrombotic state of patients with post-COVID syndrome. J Thromb Hemostasis. (2023) 21:94&#x2013;100. doi:&#xa0;10.1016/J.JTHA.2022.10.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.JTHA.2022.10.013</ArticleId><ArticleId IdType="pmc">PMC9773628</ArticleId><ArticleId IdType="pubmed">36695401</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E, Vlok M, Venter C, Bezuidenhout JA, Laubscher GJ, Steenkamp J, et al. . Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin. Cardiovasc Diabetol. (2021) 20. doi:&#xa0;10.1186/S12933-021-01359-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/S12933-021-01359-7</ArticleId><ArticleId IdType="pmc">PMC8381139</ArticleId><ArticleId IdType="pubmed">34425843</ArticleId></ArticleIdList></Reference><Reference><Citation>Joshee S, Vatti N, Chang C. Long-term effects of COVID-19. Mayo Clin Proc. (2022) 97:579&#x2013;99. doi:&#xa0;10.1016/J.MAYOCP.2021.12.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.MAYOCP.2021.12.017</ArticleId><ArticleId IdType="pmc">PMC8752286</ArticleId><ArticleId IdType="pubmed">35246288</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelin J, Wood J, Jaycox JR, Dhodapkar RM, Lu P, Gehlhausen JR, et al. . Distinguishing features of long COVID identified through immune profiling. Nature. (2023) 623:139&#x2013;48. doi:&#xa0;10.1038/s41586-023-06651-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-023-06651-y</ArticleId><ArticleId IdType="pmc">PMC10620090</ArticleId><ArticleId IdType="pubmed">37748514</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang L, Yang B, Jiang N, Fu W, He X, Zhou Y, et al. . Three-month follow-up study of survivors of coronavirus disease 2019 after discharge. J Korean Med Sci. (2020) 35(47):e418. doi:&#xa0;10.3346/JKMS.2020.35.E418</Citation><ArticleIdList><ArticleId IdType="doi">10.3346/JKMS.2020.35.E418</ArticleId><ArticleId IdType="pmc">PMC7721559</ArticleId><ArticleId IdType="pubmed">33289374</ArticleId></ArticleIdList></Reference><Reference><Citation>Bungenberg J, Humkamp K, Hohenfeld C, Rust MI, Ermis U, Dreher M, et al. . Long COVID-19: Objectifying most self-reported neurological symptoms. Ann Clin Transl Neurol. (2022) 9:141&#x2013;54. doi:&#xa0;10.1002/ACN3.51496</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ACN3.51496</ArticleId><ArticleId IdType="pmc">PMC8862437</ArticleId><ArticleId IdType="pubmed">35060361</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Kessel SAM, Olde Hartman TC, Lucassen PLBJ, Van Jaarsveld CHM. Post-acute and long-COVID-19 symptoms in patients with mild diseases: a systematic review. Fam Pract. (2022) 39:159&#x2013;67. doi:&#xa0;10.1093/FAMPRA/CMAB076</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/FAMPRA/CMAB076</ArticleId><ArticleId IdType="pmc">PMC8414057</ArticleId><ArticleId IdType="pubmed">34268556</ArticleId></ArticleIdList></Reference><Reference><Citation>Bansal R, Gubbi S, Koch CA. COVID-19 and chronic fatigue syndrome: An endocrine perspective. J Clin Transl Endocrinol. (2022) 27:100284. doi:&#xa0;10.1016/j.jcte.2021.100284</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcte.2021.100284</ArticleId><ArticleId IdType="pmc">PMC8641402</ArticleId><ArticleId IdType="pubmed">34877261</ArticleId></ArticleIdList></Reference><Reference><Citation>Salari N, Khodayari Y, Hosseinian-Far A, Zarei H, Rasoulpoor S, Akbari H, et al. . Global prevalence of chronic fatigue syndrome among long COVID-19 patients: A systematic review and meta-analysis. Biopsychosoc Med. (2022) 16:21. doi:&#xa0;10.1186/s13030-022-00250-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13030-022-00250-5</ArticleId><ArticleId IdType="pmc">PMC9589726</ArticleId><ArticleId IdType="pubmed">36274177</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Hakeim HK, Al-Rubaye HT, Al-Hadrawi DS, Almulla AF, Maes M. Long-COVID post-viral chronic fatigue and affective symptoms are associated with oxidative damage, lowered antioxidant defenses and inflammation: a proof of concept and mechanism study. Mol Psychiatry. (2022) 28:564&#x2013;78. doi:&#xa0;10.1038/s41380-022-01836-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-022-01836-9</ArticleId><ArticleId IdType="pmc">PMC9589528</ArticleId><ArticleId IdType="pubmed">36280755</ArticleId></ArticleIdList></Reference><Reference><Citation>Twomey R, Demars J, Franklin K, Nicole Culos-Reed S, Weatherald J, Wrightson JG. Chronic fatigue and postexertional malaise in people living with long COVID: an observational study. Phys Ther. (2022) 102(4):pzac005. doi:&#xa0;10.1093/PTJ/PZAC005</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/PTJ/PZAC005</ArticleId><ArticleId IdType="pmc">PMC9383197</ArticleId><ArticleId IdType="pubmed">35079817</ArticleId></ArticleIdList></Reference><Reference><Citation>Son K, Jamil R, Chowdhury A, Mukherjee M, Venegas C, Miyasaki K, et al. . Circulating anti-nuclear autoantibodies in COVID-19 survivors predict long COVID symptoms. Eur Respir J. (2023) 61:2200970. doi:&#xa0;10.1183/13993003.00970-2022</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00970-2022</ArticleId><ArticleId IdType="pmc">PMC9515477</ArticleId><ArticleId IdType="pubmed">36137590</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H, Raza S, Nowell J, Young M, Edison P. Long covid-mechanisms, risk factors, and management. BMJ. (2021) 374:n1648. doi:&#xa0;10.1136/BMJ.N1648</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/BMJ.N1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Righi E, Mirandola M, Mazzaferri F, Dossi G, Razzaboni E Zaffagnini E, et al. . Determinants of persistence of symptoms and impact on physical and mental wellbeing in Long COVID: A prospective cohort study. J Infect. (2022) 84:566&#x2013;72. doi:&#xa0;10.1016/J.JINF.2022.02.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.JINF.2022.02.003</ArticleId><ArticleId IdType="pmc">PMC8828388</ArticleId><ArticleId IdType="pubmed">35150765</ArticleId></ArticleIdList></Reference><Reference><Citation>Raveendran AV, Jayadevan R, Sashidharan S. Long COVID: an overview,&#x201d; Diabetes &amp; Metabolic syndrome. Clin Res Rev. (2021) 15:869&#x2013;75. doi:&#xa0;10.1016/J.DSX.2021.04.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.DSX.2021.04.007</ArticleId><ArticleId IdType="pmc">PMC9637465</ArticleId><ArticleId IdType="pubmed">36351871</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiech M, Chroscicki P, Swatler J, Stepnik D, De Biasi S, Hampel M, et al. . Remodeling of T cell dynamics during long COVID is dependent on severity of SARS-coV-2 infection. Front Immunol. (2022) 13:886431/BIBTEX. doi:&#xa0;10.3389/fimmu.2022.886431</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.886431</ArticleId><ArticleId IdType="pmc">PMC9226563</ArticleId><ArticleId IdType="pubmed">35757700</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo P, Ballesteros AB, Yeung SP, Liu R, Saha A, Curtis L, et al. . COVCOG 2: cognitive and memory deficits in long COVID: A second publication from the COVID and cognition study. Front Aging Neurosci. (2022) 14:804937/BIBTEX. doi:&#xa0;10.3389/fnagi.2022.804937</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2022.804937</ArticleId><ArticleId IdType="pmc">PMC8967943</ArticleId><ArticleId IdType="pubmed">35370620</ArticleId></ArticleIdList></Reference><Reference><Citation>Morioka S, Tsuzuki S, Maruki T, Terada M, Miyazato Y, Kutsuna S, et al. . Epidemiology of post-COVID conditions beyond 1 year: a cross-sectional study. Public Health. (2023) 216:39&#x2013;44. doi:&#xa0;10.1016/J.PUHE.2023.01.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.PUHE.2023.01.008</ArticleId><ArticleId IdType="pubmed">36791649</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishikura T, Nakano T, Kitano T, Tokuda T, Sumi-Akamaru H, Naka T. Serum ferritin level during hospitalization is associated with Brain Fog after COVID-19. Sci&#xa0;Rep. (2023) 13:1&#x2013;8. doi:&#xa0;10.1038/s41598-023-40011-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-40011-0</ArticleId><ArticleId IdType="pmc">PMC10421912</ArticleId><ArticleId IdType="pubmed">37567939</ArticleId></ArticleIdList></Reference><Reference><Citation>Alemanno F, Houdayer E, Parma A, Spina A, Del Forno A, Scatolini A, et al. . COVID-19 cognitive deficits after respiratory assistance in the subacute phase: A COVID-rehabilitation unit experience. PloS One. (2021) 16:e0246590. doi:&#xa0;10.1371/JOURNAL.PONE.0246590</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/JOURNAL.PONE.0246590</ArticleId><ArticleId IdType="pmc">PMC7870071</ArticleId><ArticleId IdType="pubmed">33556127</ArticleId></ArticleIdList></Reference><Reference><Citation>Castanares-Zapatero D, Chalon P, Kohn L, Dauvrin M, Detollenaere J, Maertens de Noordhout C, et al. . Pathophysiology and mechanism of long COVID: a comprehensive review. Ann Med. (2022) 54:1473&#x2013;87. doi:&#xa0;10.1080/07853890.2022.2076901</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07853890.2022.2076901</ArticleId><ArticleId IdType="pmc">PMC9132392</ArticleId><ArticleId IdType="pubmed">35594336</ArticleId></ArticleIdList></Reference><Reference><Citation>de Erausquin GA, Snyder H, Carrillo M, Hosseini AA, Brugha TS, Seshadri S. The chronic neuropsychiatric sequelae of COVID-19: The need for a prospective study of viral impact on brain functioning. Alzheimer&#x2019;s Dementia. (2021) 17:1056&#x2013;65. doi:&#xa0;10.1002/ALZ.12255</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ALZ.12255</ArticleId><ArticleId IdType="pmc">PMC10431934</ArticleId><ArticleId IdType="pubmed">33399270</ArticleId></ArticleIdList></Reference><Reference><Citation>Hugon J, Msika EF, Queneau M, Farid K, Paquet C. Long COVID: cognitive complaints (brain fog) and dysfunction of the cingulate cortex. J Neurol. (2022) 269:44&#x2013;6. doi:&#xa0;10.1007/s00415-021-10655-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10655-x</ArticleId><ArticleId IdType="pmc">PMC8211714</ArticleId><ArticleId IdType="pubmed">34143277</ArticleId></ArticleIdList></Reference><Reference><Citation>Monje M, Iwasaki A. The neurobiology of long COVID. Neuron. (2022) 110:3484&#x2013;96. doi:&#xa0;10.1016/J.NEURON.2022.10.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.NEURON.2022.10.006</ArticleId><ArticleId IdType="pmc">PMC9537254</ArticleId><ArticleId IdType="pubmed">36288726</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian T, Wu J, Chen T, Li J, Yan S, Zhou Y, et al. . Long-term follow-up of dynamic brain changes in patients recovered from COVID-19 without neurological manifestations. JCI Insight. (2022) 7(4):e155827. doi:&#xa0;10.1172/JCI.INSIGHT.155827</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI.INSIGHT.155827</ArticleId><ArticleId IdType="pmc">PMC8876627</ArticleId><ArticleId IdType="pubmed">35191397</ArticleId></ArticleIdList></Reference><Reference><Citation>Asadi-Pooya AA, Akbari A, Emami A, Lotfi M, Rostamihosseinkhani M, Nemati H, et al. . Long COVID syndrome-associated brain fog. J Med Virol. (2022) 94:979&#x2013;84. doi:&#xa0;10.1002/JMV.27404</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/JMV.27404</ArticleId><ArticleId IdType="pmc">PMC8662118</ArticleId><ArticleId IdType="pubmed">34672377</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Luciano S, Geddes JR, Harrison PJ. Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62&#x2008;354 COVID-19 cases in the USA. Lancet Psychiatry. (2021) 8:130&#x2013;40. doi:&#xa0;10.1016/S2215-0366(20)30462-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(20)30462-4</ArticleId><ArticleId IdType="pmc">PMC7820108</ArticleId><ArticleId IdType="pubmed">33181098</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re&#x2019;em Y, et al. . Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. (2021) 38. doi:&#xa0;10.1016/j.eclinm.2021.101019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Tana C, Bentivegna E, Cho SJ, Harriott AM, Garc&#xed;a-Azor&#xed;n D, Labastida-Ramirez A, et al. . Long COVID headache. J Headache Pain. (2022) 23:1&#x2013;12. doi:&#xa0;10.1186/s10194-022-01450-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s10194-022-01450-8</ArticleId><ArticleId IdType="pmc">PMC9340759</ArticleId><ArticleId IdType="pubmed">35915417</ArticleId></ArticleIdList></Reference><Reference><Citation>Caronna E, Alpuente A, Torres-Ferrus M, Pozo-Rosich P. Toward a better understanding of persistent headache after mild COVID-19: Three migraine-like yet distinct scenarios. Headache. (2021) 61:1277&#x2013;80. doi:&#xa0;10.1111/HEAD.14197</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/HEAD.14197</ArticleId><ArticleId IdType="pmc">PMC8444902</ArticleId><ArticleId IdType="pubmed">34363619</ArticleId></ArticleIdList></Reference><Reference><Citation>Trigo J, Garc&#xed;a-Azor&#xed;n D, Planchuelo-G&#xf3;mez A, Mart&#xed;nez-P&#xed;as E, Talavera B, Hern&#xe1;ndez-P&#xe9;rez I, et al. . Factors associated with the presence of headache in hospitalized COVID-19 patients and impact on prognosis: a retrospective cohort study. J Headache Pain. (2020) 21. doi:&#xa0;10.1186/S10194-020-01165-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/S10194-020-01165-8</ArticleId><ArticleId IdType="pmc">PMC7388434</ArticleId><ArticleId IdType="pubmed">32727345</ArticleId></ArticleIdList></Reference><Reference><Citation>Iqbal FM, Lam K, Sounderajah V, Clarke JM, Ashrafian H, Darzi A. Characteristics and predictors of acute and chronic post-COVID syndrome: A systematic review and meta-analysis. EClinicalMedicine. (2021), 100899. doi:&#xa0;10.1016/j.eclinm.2021.100899</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.100899</ArticleId><ArticleId IdType="pmc">PMC8141371</ArticleId><ArticleId IdType="pubmed">34036253</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C, Navarro-Santana M, G&#xf3;mez-Mayordomo V, Cuadrado ML, Garc&#xed;a-Azor&#xed;n D, Arendt-Nielsen L, et al. . Headache as an acute and post-COVID-19 symptom in COVID-19 survivors: A meta-analysis of the current literature. Eur J Neurol. (2021) 28:3820&#x2013;5. doi:&#xa0;10.1111/ene.15040</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.15040</ArticleId><ArticleId IdType="pmc">PMC8444899</ArticleId><ArticleId IdType="pubmed">34327787</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandal S, Barnett J, Brill SE, Brown JS, Denneny EK, Hare SS, et al. . Long-COVID&#x2019;: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalization for COVID-19. Thorax. (2021) 76:396&#x2013;8. doi:&#xa0;10.1136/THORAXJNL-2020-215818</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/THORAXJNL-2020-215818</ArticleId><ArticleId IdType="pmc">PMC7615158</ArticleId><ArticleId IdType="pubmed">33172844</ArticleId></ArticleIdList></Reference><Reference><Citation>Caspersen IH, Magnus P, Trogstad L. Excess risk and clusters of symptoms after COVID-19 in a large Norwegian cohort. Eur J Epidemiol. (2022) 37:539&#x2013;48. doi:&#xa0;10.1007/S10654-022-00847-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/S10654-022-00847-8</ArticleId><ArticleId IdType="pmc">PMC8872922</ArticleId><ArticleId IdType="pubmed">35211871</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinzon RT, Wijaya VO, Al Jody A, Nunsio PN, Buana RB. Persistent neurological manifestations in long COVID-19 syndrome: A systematic review and meta-analysis. J Infect Public Health. (2022) 15:856&#x2013;69. doi:&#xa0;10.1016/J.JIPH.2022.06.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.JIPH.2022.06.013</ArticleId><ArticleId IdType="pmc">PMC9221935</ArticleId><ArticleId IdType="pubmed">35785594</ArticleId></ArticleIdList></Reference><Reference><Citation>Da Costa BA, Silva L, Mendes M, Karmann I, Campos B, Nogueira M, et al. . Anxiety and depression are associated with limbic atrophy and severe disruption of brain functional connectivity after mild COVID-19 infection (S21.007). J Alzheimer&#x2019;s Dis (2023) 96(4):1711&#x2013;20. doi:&#xa0;10.3233/JAD-230632</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-230632</ArticleId></ArticleIdList></Reference><Reference><Citation>Efstathiou V, Stefanou MI, Demetriou M, Siafakas N, Makris M, Tsivgoulis G, et al. . Long COVID and neuropsychiatric manifestations (Review). Exp Ther Med. (2022) 23(5):363. doi:&#xa0;10.3892/ETM.2022.11290</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ETM.2022.11290</ArticleId><ArticleId IdType="pmc">PMC9019760</ArticleId><ArticleId IdType="pubmed">35493431</ArticleId></ArticleIdList></Reference><Reference><Citation>Mekhael M, Lim CH, El Hajjar AH, Noujaim C, Pottle C, Makan N, et al. . Studying the effect of long COVID-19 infection on sleep quality using wearable health devices: observational study. J Med Internet Res. (2022) 24(7):e38000. doi:&#xa0;10.2196/38000</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/38000</ArticleId><ArticleId IdType="pmc">PMC9258734</ArticleId><ArticleId IdType="pubmed">35731968</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer A, Zhang L, Elb&#xe9;ji A, Wilmes P, Oustric P, Staub T, et al. . Long COVID symptomatology after 12 months and its impact on quality of life according to initial coronavirus disease 2019 disease severity. Open Forum Infect Dis. (2022) 9(8):ofac397. doi:&#xa0;10.1093/OFID/OFAC397</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/OFID/OFAC397</ArticleId><ArticleId IdType="pmc">PMC9379809</ArticleId><ArticleId IdType="pubmed">35983269</ArticleId></ArticleIdList></Reference><Reference><Citation>See&#x3b2;le J, Waterboer T, Hippchen T, Simon J, Kirchner M, Lim A, et al. . Persistent symptoms in adult patients 1 year after coronavirus disease 2019 (COVID-19): A prospective cohort study. Clin Infect Dis. (2022) 74:1191&#x2013;8. doi:&#xa0;10.1093/CID/CIAB611</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/CID/CIAB611</ArticleId><ArticleId IdType="pmc">PMC8394862</ArticleId><ArticleId IdType="pubmed">34223884</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z, Zhang Z, Zhang Z, Wang Z, Li H. Cognitive impairment after long COVID-19: current evidence and perspectives. Front Neurol. (2023) 14:1239182/BIBTEX. doi:&#xa0;10.3389/fneur.2023.1239182</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2023.1239182</ArticleId><ArticleId IdType="pmc">PMC10423939</ArticleId><ArticleId IdType="pubmed">37583958</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Geddes JR, Husain M, Luciano S, Harrison PJ. 6-month neurological and psychiatric outcomes in 236&#x2009;379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. (2021) 8:416&#x2013;27. doi:&#xa0;10.1016/S2215-0366(21)00084-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(21)00084-5</ArticleId><ArticleId IdType="pmc">PMC8023694</ArticleId><ArticleId IdType="pubmed">33836148</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Skorniewska Z, Hampshire A, Chalmers JD, Ho LP, Horsley A, et al. . Acute blood biomarker profiles predict cognitive deficits 6 and 12 months after COVID-19 hospitalization. Nat Med. (2023) 29:2498&#x2013;508. doi:&#xa0;10.1038/s41591-023-02525-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-023-02525-y</ArticleId><ArticleId IdType="pmc">PMC10579097</ArticleId><ArticleId IdType="pubmed">37653345</ArticleId></ArticleIdList></Reference><Reference><Citation>Conway EM, Mackman N, Warren RQ, Wolberg AS, Mosnier LO, Campbell RA, et al. . Understanding COVID-19-associated coagulopathy. Nat Rev Immunol. (2022) 22:639&#x2013;49. doi:&#xa0;10.1038/s41577-022-00762-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-022-00762-9</ArticleId><ArticleId IdType="pmc">PMC9362465</ArticleId><ArticleId IdType="pubmed">35931818</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen MA, Ryu JK, Akassoglou K. Fibrinogen in neurological diseases: mechanisms, imaging and therapeutics. Nat Rev Neurosci. (2018) 19:283&#x2013;301. doi:&#xa0;10.1038/nrn.2018.13</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn.2018.13</ArticleId><ArticleId IdType="pmc">PMC6743980</ArticleId><ArticleId IdType="pubmed">29618808</ArticleId></ArticleIdList></Reference><Reference><Citation>Grasselli G, Tonetti T, Protti A, Langer T, Girardis M, Bellani G, et al. . Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicenter prospective observational study. Lancet Respir Med. (2020) 8:1201&#x2013;8. doi:&#xa0;10.1016/S2213-2600(20)30370-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30370-2</ArticleId><ArticleId IdType="pmc">PMC7834127</ArticleId><ArticleId IdType="pubmed">32861276</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen MS, Kristiansen MF, Hanusson KD, Foldbo BM, Danielsen ME, Steig BA, et al. . Prevalence of long COVID in a national cohort: longitudinal measures from disease onset until 8 months&#x2019; follow-up. Int J Infect Dis. (2022) 122:437. doi:&#xa0;10.1016/J.IJID.2022.06.031</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.IJID.2022.06.031</ArticleId><ArticleId IdType="pmc">PMC9222150</ArticleId><ArticleId IdType="pubmed">35753603</ArticleId></ArticleIdList></Reference><Reference><Citation>Deer RR, Rock MA, Vasilevsky N, Carmody L, Rando H, Anzalone AJ, et al. . Characterizing long COVID: deep phenotype of a complex condition. EBioMedicine. (2021) 74. doi:&#xa0;10.1016/J.EBIOM.2021.103722</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.EBIOM.2021.103722</ArticleId><ArticleId IdType="pmc">PMC8613500</ArticleId><ArticleId IdType="pubmed">34839263</ArticleId></ArticleIdList></Reference><Reference><Citation>Najafloo R, Majidi J, Asghari A, Aleemardani M, Kamrava SK, Simorgh S, et al. . Mechanism of anosmia caused by symptoms of COVID-19 and emerging treatments. ACS Chem Neurosci. (2021) 12:3795&#x2013;805. doi:&#xa0;10.1021/ACSCHEMNEURO.1C00477</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ACSCHEMNEURO.1C00477</ArticleId><ArticleId IdType="pubmed">34609841</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung S, Allali G, Benzakour L, Nuber-Champier A, Thomasson M, Jacot de Alc&#xe2;ntara I, et al. . Long COVID neuropsychological deficits after severe, moderate, or mild infection. Clin Trans Neurosci. (2022) 6:9. doi:&#xa0;10.3390/CTN6020009</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/CTN6020009</ArticleId></ArticleIdList></Reference><Reference><Citation>Boscolo-Rizzo P, Spinato G, Hopkins C, Marzolino R, Cavicchia A, Zucchini S, et al. . Evaluating long-term smell or taste dysfunction in mildly symptomatic COVID-19 patients: a 3-year follow-up study. Eur Arch Otorhinolaryngol. (2023) 280:5625&#x2013;30. doi:&#xa0;10.1007/s00405-023-08227-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00405-023-08227-y</ArticleId><ArticleId IdType="pubmed">37715807</ArticleId></ArticleIdList></Reference><Reference><Citation>Lupi L, Bordin A, Sales G, Colaianni D, Vitiello A, Biscontin Av, et al. . Persistent and transient olfactory deficits in COVID-19 are associated to inflammation and zinc homeostasis. Front Immunol. (2023) 14:1148595. doi:&#xa0;10.3389/fimmu.2023.1148595</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1148595</ArticleId><ArticleId IdType="pmc">PMC10380959</ArticleId><ArticleId IdType="pubmed">37520523</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaira LA, Gessa C, Deiana G, Salzano G, Maglitto F, Lechien JRv, et al. . The effects of persistent olfactory and gustatory dysfunctions on quality of life in long-COVID-19 patients. Life. (2022) 12:141. doi:&#xa0;10.3390/LIFE12020141</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/LIFE12020141</ArticleId><ArticleId IdType="pmc">PMC8878431</ArticleId><ArticleId IdType="pubmed">35207429</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan Z, Yang M, Lai CL. Long COVID-19 syndrome: A comprehensive review of its effect on various organ systems and recommendation on rehabilitation plans. Biomedicines. (2021) 9(8):966. doi:&#xa0;10.3390/BIOMEDICINES9080966</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/BIOMEDICINES9080966</ArticleId><ArticleId IdType="pmc">PMC8394513</ArticleId><ArticleId IdType="pubmed">34440170</ArticleId></ArticleIdList></Reference><Reference><Citation>Yende S, Parikh CR. Long COVID and kidney disease. Nat Rev Nephrol. (2021) 17:792&#x2013;3. doi:&#xa0;10.1038/s41581-021-00487-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41581-021-00487-3</ArticleId><ArticleId IdType="pmc">PMC8427150</ArticleId><ArticleId IdType="pubmed">34504319</ArticleId></ArticleIdList></Reference><Reference><Citation>Silver SA, Beaubien-Souligny W, Shah PS, Harel S, Blum D, Kishibe T, et al. . The prevalence of acute kidney injury in patients hospitalized with COVID-19 infection: A systematic review and meta-analysis. Kidney Med. (2021) 3:83&#x2013;98.e1. doi:&#xa0;10.1016/j.xkme.2020.11.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xkme.2020.11.008</ArticleId><ArticleId IdType="pmc">PMC7723763</ArticleId><ArticleId IdType="pubmed">33319190</ArticleId></ArticleIdList></Reference><Reference><Citation>Blackett JW, Wainberg M, Elkind MSV, Freedberg DE. Potential long coronavirus disease 2019 gastrointestinal symptoms 6 months after coronavirus infection are associated with mental health symptoms. Gastroenterology. (2022) 162:648&#x2013;650.e2. doi:&#xa0;10.1053/J.GASTRO.2021.10.040</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/J.GASTRO.2021.10.040</ArticleId><ArticleId IdType="pmc">PMC8556689</ArticleId><ArticleId IdType="pubmed">34728186</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrade BS, Siqueira S, de Assis Soares WR, de Souza Rangel F, Santos NO, dos Santos Freitas A, et al. . Long-COVID and post-COVID health complications: an up-to-date review on clinical conditions and their possible molecular mechanisms. Viruses. (2021) 13(4):700. doi:&#xa0;10.3390/V13040700</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/V13040700</ArticleId><ArticleId IdType="pmc">PMC8072585</ArticleId><ArticleId IdType="pubmed">33919537</ArticleId></ArticleIdList></Reference><Reference><Citation>Gal&#xe1;n M, Vig&#xf3;n L, Fuertes D, Murciano-Ant&#xf3;n MACasado-Fern&#xe1;ndez G, Dom&#xed;nguez-Mateos S, et al. . Persistent overactive cytotoxic immune response in a spanish cohort of individuals with long-COVID: identification of diagnostic biomarkers. Front Immunol. (2022) 13:848886/BIBTEX. doi:&#xa0;10.3389/fimmu.2022.848886</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.848886</ArticleId><ArticleId IdType="pmc">PMC8990790</ArticleId><ArticleId IdType="pubmed">35401523</ArticleId></ArticleIdList></Reference><Reference><Citation>Tate W, Walker M, Sweetman E, Helliwell A, Peppercorn K, Edgar C, et al. . Molecular mechanisms of neuroinflammation in ME/CFS and long COVID to sustain disease and promote relapses. Front Neurol. (2022) 13:877772/BIBTEX. doi:&#xa0;10.3389/fneur.2022.877772</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2022.877772</ArticleId><ArticleId IdType="pmc">PMC9174654</ArticleId><ArticleId IdType="pubmed">35693009</ArticleId></ArticleIdList></Reference><Reference><Citation>Hastie CE, Lowe DJ, McAuley A, Winter AJ, Mills NL, Black C, et al. . Outcomes among confirmed cases and a matched comparison group in the Long-COVID in Scotland study. Nat Commun. (2022) 13. doi:&#xa0;10.1038/S41467-022-33415-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/S41467-022-33415-5</ArticleId><ArticleId IdType="pmc">PMC9556711</ArticleId><ArticleId IdType="pubmed">36224173</ArticleId></ArticleIdList></Reference><Reference><Citation>Healey Q, Sheikh A, Daines L, Vasileiou E. Symptoms and signs of long COVID: A rapid review and meta-analysis. J Glob Health. (2022) 12:5014. doi:&#xa0;10.7189/JOGH.12.05014</Citation><ArticleIdList><ArticleId IdType="doi">10.7189/JOGH.12.05014</ArticleId><ArticleId IdType="pmc">PMC9125197</ArticleId><ArticleId IdType="pubmed">35596571</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadi HAR, Carr CS, Al Suwaidi J. Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome. Vasc Health Risk Manag. (2005) 1:183.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1993955</ArticleId><ArticleId IdType="pubmed">17319104</ArticleId></ArticleIdList></Reference><Reference><Citation>Kruger A, Vlok M, Turner S, Venter C, Laubscher GJ, Kell DB, et al. . Proteomics of fibrin amyloid microclots in long COVID/post-acute sequelae of COVID-19 (PASC) shows many entrapped pro-inflammatory molecules that may also contribute to a failed fibrinolytic system. Cardiovasc Diabetol. (2022) 21(1):190. doi:&#xa0;10.1186/S12933-022-01623-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/S12933-022-01623-4</ArticleId><ArticleId IdType="pmc">PMC9491257</ArticleId><ArticleId IdType="pubmed">36131342</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell DB, Laubscher GJ, Pretorius E. A central role for amyloid fibrin microclots in long COVID/PASC: origins and therapeutic implications. Biochem J. (2022) 479:537&#x2013;59. doi:&#xa0;10.1042/BCJ20220016</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BCJ20220016</ArticleId><ArticleId IdType="pmc">PMC8883497</ArticleId><ArticleId IdType="pubmed">35195253</ArticleId></ArticleIdList></Reference><Reference><Citation>Leng A, Shah M, Ahmad SA, Premraj L, Wildi K, Bassi GL, et al. . Pathogenesis underlying neurological manifestations of long COVID syndrome and potential therapeutics. Cells. (2023) 12(5):816. doi:&#xa0;10.3390/CELLS12050816</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/CELLS12050816</ArticleId><ArticleId IdType="pmc">PMC10001044</ArticleId><ArticleId IdType="pubmed">36899952</ArticleId></ArticleIdList></Reference><Reference><Citation>von Meijenfeldt FA, Havervall S, Adelmeijer J, Lundstr&#xf6;m A, Magnusson M, Mackman N, et al. . Sustained prothrombotic changes in COVID-19 patients 4 months after hospital discharge. Blood Adv. (2021) 5:756&#x2013;9. doi:&#xa0;10.1182/BLOODADVANCES.2020003968</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/BLOODADVANCES.2020003968</ArticleId><ArticleId IdType="pmc">PMC7857699</ArticleId><ArticleId IdType="pubmed">33560386</ArticleId></ArticleIdList></Reference><Reference><Citation>Willems LH, Nagy M, Ten Cate H, Spronk H, Groh LA, et al. . Sustained inflammation, coagulation activation and elevated endothelin-1 levels without macrovascular dysfunction at 3 months after COVID-19. Thromb Res. (2022) 209:106&#x2013;14. doi:&#xa0;10.1016/J.THROMRES.2021.11.027</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.THROMRES.2021.11.027</ArticleId><ArticleId IdType="pmc">PMC8642246</ArticleId><ArticleId IdType="pubmed">34922160</ArticleId></ArticleIdList></Reference><Reference><Citation>Mancini I, Baronciani L, Artoni A, Colpani P, Biganzoli M, Cozzi G, et al. . The ADAMTS13-von Willebrand factor axis in COVID-19 patients. J Thromb Haemost. (2021) 19:513&#x2013;21. doi:&#xa0;10.1111/JTH.15191</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/JTH.15191</ArticleId><ArticleId IdType="pmc">PMC7753796</ArticleId><ArticleId IdType="pubmed">33230904</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasannan N, Heightman M, Hillman T, Wall E, Bell R, Kessler A, et al. . Impaired exercise capacity in post-COVID-19 syndrome: the role of VWF-ADAMTS13 axis. Blood Adv. (2022) 6:4041&#x2013;8. doi:&#xa0;10.1182/BLOODADVANCES.2021006944</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/BLOODADVANCES.2021006944</ArticleId><ArticleId IdType="pmc">PMC9098525</ArticleId><ArticleId IdType="pubmed">35543533</ArticleId></ArticleIdList></Reference><Reference><Citation>Besnier F, B&#xe9;rub&#xe9; B, Malo J, Gagnon C, Gr&#xe9;goire Ca Juneau M, et al. . Cardiopulmonary rehabilitation in long-COVID-19 patients with persistent breathlessness and fatigue: the COVID-rehab study. Int J Environ Res Public Health. (2022) 19(7):4133. doi:&#xa0;10.3390/IJERPH19074133</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/IJERPH19074133</ArticleId><ArticleId IdType="pmc">PMC8998214</ArticleId><ArticleId IdType="pubmed">35409815</ArticleId></ArticleIdList></Reference><Reference><Citation>Bitirgen G, Korkmaz C, Zamani A, Ozkagnici A, Zengin N, Ponirakis G, et al. . Corneal confocal microscopy identifies corneal nerve fiber loss and increased dendritic cells in patients with long COVID. Br J Ophthalmol. (2022) 106:1635&#x2013;41. doi:&#xa0;10.1136/BJOPHTHALMOL-2021-319450</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/BJOPHTHALMOL-2021-319450</ArticleId><ArticleId IdType="pmc">PMC8359871</ArticleId><ArticleId IdType="pubmed">34312122</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C, Yu C, Jing H, Wu X, Novakovic VA, Xie R, et al. . Long COVID: the nature of thrombotic sequelae determines the necessity of early anticoagulation. Front Cell Infect Microbiol. (2022) 12:861703/BIBTEX. doi:&#xa0;10.3389/fcimb.2022.861703</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.861703</ArticleId><ArticleId IdType="pmc">PMC9016198</ArticleId><ArticleId IdType="pubmed">35449732</ArticleId></ArticleIdList></Reference><Reference><Citation>Naendrup JH, Garcia Borrega J, Eichenauer DA, Shimabukuro-Vornhagen A, Kochanek M, B&#xf6;ll B. Reactivation of EBV and CMV in severe COVID-19&#x2014;Epiphenomena or trigger of hyperinflammation in need of treatment? A large case series of critically ill patients. J Intensive Care Med. (2022) 37:1152. doi:&#xa0;10.1177/08850666211053990</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/08850666211053990</ArticleId><ArticleId IdType="pmc">PMC9396115</ArticleId><ArticleId IdType="pubmed">34791940</ArticleId></ArticleIdList></Reference><Reference><Citation>Manoharan S, Ying LY. Epstein Barr Virus Reactivation during COVID-19 Hospitalization Significantly Increased Mortality/Death in SARS-CoV-2(+)/EBV(+) than SARS-CoV-2(+)/EBV(&#x2013;) Patients: A Comparative Meta-Analysis. Int J Clin Pract. (2023) 2023. doi:&#xa0;10.1155/2023/1068000</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2023/1068000</ArticleId><ArticleId IdType="pmc">PMC9904914</ArticleId><ArticleId IdType="pubmed">36793928</ArticleId></ArticleIdList></Reference><Reference><Citation>Rohrhofer J, Graninger M, Lettenmaier L, Schweighardt J, Gentile SA, Koidl L, et al. . Association between Epstein-Barr-Virus reactivation and development of Long-COVID fatigue. Allergy. (2023) 78:297&#x2013;9. doi:&#xa0;10.1111/ALL.15471</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ALL.15471</ArticleId><ArticleId IdType="pmc">PMC9538037</ArticleId><ArticleId IdType="pubmed">35950630</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasl SV, Evans AS, Niederman JC. Psychosocial risk factors in the developmental of infectious mononucleosis. Psychosom Med. (1979) 41:445&#x2013;66. doi:&#xa0;10.1097/00006842-197910000-00002</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00006842-197910000-00002</ArticleId><ArticleId IdType="pubmed">231279</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinstock LB, Brook JB, Walters AS, Goris A, Afrin LB, Molderings GJ. Mast cell activation symptoms are prevalent in Long-COVID. Int J Infect Dis. (2021) 112:217&#x2013;26. doi:&#xa0;10.1016/j.ijid.2021.09.043</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2021.09.043</ArticleId><ArticleId IdType="pmc">PMC8459548</ArticleId><ArticleId IdType="pubmed">34563706</ArticleId></ArticleIdList></Reference><Reference><Citation>Oaklander AL, Mills AJ, Kelley M, Toran LS, Smith B, Dalakas MC, et al. . Peripheral Neuropathy Evaluations of Patients With Prolonged Long COVID,&#x201d;. Neurology. Neuroimmunology &amp; Neuroinflammation (2022) 9(3):. doi:&#xa0;10.1212/NXI.0000000000001146</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000001146</ArticleId><ArticleId IdType="pmc">PMC8889896</ArticleId><ArticleId IdType="pubmed">35232750</ArticleId></ArticleIdList></Reference><Reference><Citation>Karaarslan F, G&#xfc;neri FD, Karde&#x15f; S. Long COVID: rheumatologic/musculoskeletal symptoms in hospitalized COVID-19 survivors at 3 and 6 months. Clin Rheumatol. (2022) 41:289&#x2013;96. doi:&#xa0;10.1007/s10067-021-05942-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-021-05942-x</ArticleId><ArticleId IdType="pmc">PMC8553494</ArticleId><ArticleId IdType="pubmed">34713356</ArticleId></ArticleIdList></Reference><Reference><Citation>Chadda KR, Blakey EE, Huang CLH, Jeevaratnam K. Long COVID-19 and postural orthostatic tachycardia syndromeIs dysautonomia to be blamed? Front Cardiovasc Med. (2022) 9:860198/BIBTEX. doi:&#xa0;10.3389/fcvm.2022.860198</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2022.860198</ArticleId><ArticleId IdType="pmc">PMC8959615</ArticleId><ArticleId IdType="pubmed">35355961</ArticleId></ArticleIdList></Reference><Reference><Citation>Saini G, Aneja R. Cancer as a prospective sequela of long COVID-19. Bioessays. (2021) 43(6):2000331. doi:&#xa0;10.1002/BIES.202000331</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/BIES.202000331</ArticleId><ArticleId IdType="pmc">PMC8206711</ArticleId><ArticleId IdType="pubmed">33914346</ArticleId></ArticleIdList></Reference><Reference><Citation>Sapkota HR, Nune A. Long COVID from rheumatology perspective - a narrative review. Clin Rheumatol. (2022) 41:337&#x2013;48. doi:&#xa0;10.1007/S10067-021-06001-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/S10067-021-06001-1</ArticleId><ArticleId IdType="pmc">PMC8629735</ArticleId><ArticleId IdType="pubmed">34845562</ArticleId></ArticleIdList></Reference><Reference><Citation>McMahon DE, Gallman AE, Hruza GJ, Rosenbach M, Lipoff J, Desai SR, et al. . Long COVID in the skin: a registry analysis of COVID-19 dermatological duration. Lancet Infect Dis. (2021) 21:313&#x2013;4. doi:&#xa0;10.1016/S1473-3099(20)30986-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30986-5</ArticleId><ArticleId IdType="pmc">PMC7836995</ArticleId><ArticleId IdType="pubmed">33460566</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong-Chew RM, Rodr&#xed;guez Valdez CA, Lomelin-Gascon J, Morales-Ju&#xe1;rez L, Rodr&#xed;guez de la Cerda ML, et al. . Symptom cluster analysis of long COVID-19 in patients discharged from the Temporary COVID-19 Hospital in Mexico City. Ther Adv Infect Dis. (2022) 9:1&#x2013;17. doi:&#xa0;10.1177/20499361211069264</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/20499361211069264</ArticleId><ArticleId IdType="pmc">PMC8764618</ArticleId><ArticleId IdType="pubmed">35059196</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Al-Aly Z. Risks and burdens of incident diabetes in long COVID: a cohort study. Lancet Diabetes Endocrinol. (2022) 10:311&#x2013;21. doi:&#xa0;10.1016/S2213-8587(22)00044-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(22)00044-4</ArticleId><ArticleId IdType="pmc">PMC8937253</ArticleId><ArticleId IdType="pubmed">35325624</ArticleId></ArticleIdList></Reference><Reference><Citation>Raveendran AV, Misra A. Post COVID-19 syndrome (&#x2018;Long COVID&#x2019;) and diabetes: challenges in diagnosis and management. Diabetes Metab Syndrome: Clin Res Rev. (2021) 15:102235. doi:&#xa0;10.1016/J.DSX.2021.102235</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.DSX.2021.102235</ArticleId><ArticleId IdType="pmc">PMC8317446</ArticleId><ArticleId IdType="pubmed">34384972</ArticleId></ArticleIdList></Reference><Reference><Citation>Rezel-Potts E, Douiri A, Sun X, Chowienczyk PJ, Shah AM, Gulliford MC. Cardiometabolic outcomes up to 12 months after COVID-19 infection. A matched cohort study in the UK. PloS Med. (2022) 19(7):e1004052. doi:&#xa0;10.1371/JOURNAL.PMED.1004052</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/JOURNAL.PMED.1004052</ArticleId><ArticleId IdType="pmc">PMC9295991</ArticleId><ArticleId IdType="pubmed">35853019</ArticleId></ArticleIdList></Reference><Reference><Citation>Harding JL, Oviedo SA, Ali MK, Ofotokun I, Gander JC, Patel SA, et al. . The bidirectional association between diabetes and long-COVID-19 - A systematic review. Diabetes Res Clin Pract. (2023) 195. doi:&#xa0;10.1016/J.DIABRES.2022.110202</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.DIABRES.2022.110202</ArticleId><ArticleId IdType="pmc">PMC9727969</ArticleId><ArticleId IdType="pubmed">36496030</ArticleId></ArticleIdList></Reference><Reference><Citation>MacPherson K, Cooper K, Harbour J, Mahal D, Miller C, Nairn M. Experiences of living with long COVID and of accessing healthcare services: a qualitative systematic review. BMJ Open. (2022) 12:e050979. doi:&#xa0;10.1136/BMJOPEN-2021-050979</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/BMJOPEN-2021-050979</ArticleId><ArticleId IdType="pmc">PMC8753091</ArticleId><ArticleId IdType="pubmed">35017239</ArticleId></ArticleIdList></Reference><Reference><Citation>Orr&#xf9; G, Bertelloni D, Diolaiuti F, Mucci F, Di Giuseppe M, Biella M, et al. . Long-COVID syndrome? A study on the persistence of neurological, psychological and physiological symptoms. Healthcare (Basel). (2021) 9(5):575. doi:&#xa0;10.3390/HEALTHCARE9050575</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/HEALTHCARE9050575</ArticleId><ArticleId IdType="pmc">PMC8152255</ArticleId><ArticleId IdType="pubmed">34068009</ArticleId></ArticleIdList></Reference><Reference><Citation>Watson DLB, Campbell M, Hopkins C, Smith B, Kelly C, Deary V. Altered smell and taste: Anosmia, parosmia and the impact of long Covid-19. PloS One. (2021) 16(9):e0256998. doi:&#xa0;10.1371/JOURNAL.PONE.0256998</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/JOURNAL.PONE.0256998</ArticleId><ArticleId IdType="pmc">PMC8462678</ArticleId><ArticleId IdType="pubmed">34559820</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai F, Tomasoni D, Falcinella C, Barbanotti D, Castoldi R, Mul&#xe8; G, et al. . Female gender is associated with long COVID syndrome: a prospective cohort study. Clin Microbiol Infect. (2022) 28:611.e9&#x2013;611.e16. doi:&#xa0;10.1016/J.CMI.2021.11.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.CMI.2021.11.002</ArticleId><ArticleId IdType="pmc">PMC8575536</ArticleId><ArticleId IdType="pubmed">34763058</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan FJ, Hope CM, Masavuli MG, Lynn MA, Mekonnen ZA, Yeow AE, et al. . Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection. BMC Med. (2022) 20:26. doi:&#xa0;10.1186/s12916-021-02228-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-021-02228-6</ArticleId><ArticleId IdType="pmc">PMC8758383</ArticleId><ArticleId IdType="pubmed">35027067</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y, Yuan D, Chen DG, Ng R, Wang K, Choi J, et al. . Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. (2022) 185(5):881&#x2013;895.e20. doi:&#xa0;10.1016/j.cell.2022.01.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Arish M, Qian W, Narasimhan H, Siu J. COVID-19 immunopathology: From acute diseases to chronic sequelae. J Med Virol. (2023) 95:e28122. doi:&#xa0;10.1002/jmv.28122</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28122</ArticleId><ArticleId IdType="pmc">PMC9537925</ArticleId><ArticleId IdType="pubmed">36056655</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicolai N, Kaiser R, Stark K. Thromboinflammation in long COVID&#x2014;the elusive key to postinfection sequelae? J Thromb Haemost. (2023) 21:2020&#x2013;31. doi:&#xa0;10.1016/j.jtha.2023.04.039</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtha.2023.04.039</ArticleId><ArticleId IdType="pmc">PMC10174338</ArticleId><ArticleId IdType="pubmed">37178769</ArticleId></ArticleIdList></Reference><Reference><Citation>Chun HI, Coutavas E, Pine AB, Lee AI, Yu VL, Shallow MK, et al. . Immunofibrotic drivers of impaired lung function in postacute sequelae of SARS-CoV-2 infection. JCI Insight. (2021) 6:e148476. doi:&#xa0;10.1172/jci.insight.148476</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.148476</ArticleId><ArticleId IdType="pmc">PMC8410030</ArticleId><ArticleId IdType="pubmed">34111030</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsuhakara T, Brann D, Datta SR. Mechanisms of SARS-coV-2-associated anosmia. Physiol Rev. (2023) 103:2759&#x2013;66. doi:&#xa0;10.1152/physrev.00012.2023</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00012.2023</ArticleId><ArticleId IdType="pmc">PMC10625840</ArticleId><ArticleId IdType="pubmed">37342077</ArticleId></ArticleIdList></Reference><Reference><Citation>Galv&#xe1;n-Pe&#xf1;a S, Leon J, Chowdhary K, Michelson DA, Vijaykumar B, Yang L, et al. . Profound Treg perturbations correlate with COVID-19 severity. PNAS. (2021) 118:e2111315118. doi:&#xa0;10.1073/pnas.211131511</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.211131511</ArticleId><ArticleId IdType="pmc">PMC8449354</ArticleId><ArticleId IdType="pubmed">34433692</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhawan M, Rabaan AA, Alwarthan S, Alhajri M, Halwani MA, Alshengeti A, et al. . Regulatory T cells (Tregs) and COVID-19: unveiling the mechanisms, and therapeutic potentialities with a special focus on long COVID. Vaccines. (2023) 11:699. doi:&#xa0;10.3390/vaccines11030699</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines11030699</ArticleId><ArticleId IdType="pmc">PMC10059134</ArticleId><ArticleId IdType="pubmed">36992283</ArticleId></ArticleIdList></Reference><Reference><Citation>Cron RQ. Immunologic prediction of long COVID. Nat Immunol. (2023) 24:207&#x2013;8. doi:&#xa0;10.1038/s41590-022-01396-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-022-01396-8</ArticleId><ArticleId IdType="pubmed">36717724</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng HY, Xu M, Yang CX, Tian RR, Zhang M, Li JJ, et al. . Longitudinal transcriptome analyses show robust T cell immunity during recovery from COVID-19. Sig Transduct Target Ther. (2020) 5(1):294. doi:&#xa0;10.1038/s41392-020-00457-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-020-00457-4</ArticleId><ArticleId IdType="pmc">PMC7758413</ArticleId><ArticleId IdType="pubmed">33361761</ArticleId></ArticleIdList></Reference><Reference><Citation>Haunhorst S, Bloch W, Javelle F, Kr&#xfc;ger K, Baumgart S, Drube S, et al. . A scoping review of regulatory T cell dynamics in convalescent COVID-19 patients - indications for their potential involvement in the development of Long COVID? Front Immunol. (2022) 13:1070994. doi:&#xa0;10.3389/fimmu.2022.1070994</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.1070994</ArticleId><ArticleId IdType="pmc">PMC9792979</ArticleId><ArticleId IdType="pubmed">36582234</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson RC, Simons NW, Wilkins L, Cheng E, Del Valle DM, Hoffman Ge, et al. . Acute COVID-19 gene-expression profiles show multiple etiologies of long-term sequelae. medRxi. (2021). doi:&#xa0;10.1101/2021.10.04.21264434</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.10.04.21264434</ArticleId></ArticleIdList></Reference><Reference><Citation>Asadi-Pooya AA, Akbari A, Emami A, Lotfi M, Rostamihosseinkhani M, Nemati H, et al. . Risk factors associated with long COVID syndrome: A retrospective study. Iran J Med Sci. (2021) 46:428&#x2013;36. doi:&#xa0;10.30476/IJMS.2021.92080.2326</Citation><ArticleIdList><ArticleId IdType="doi">10.30476/IJMS.2021.92080.2326</ArticleId><ArticleId IdType="pmc">PMC8611223</ArticleId><ArticleId IdType="pubmed">34840383</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacob L, Koyanagi A, Smith L, Tanislav C, Konrad M, van der Beck S, et al. . Prevalence of, and factors associated with, long-term COVID-19 sick leave in working-age patients followed in general practices in Germany. Int J Infect Dis. (2021) 109:203&#x2013;8. doi:&#xa0;10.1016/J.IJID.2021.06.063</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.IJID.2021.06.063</ArticleId><ArticleId IdType="pmc">PMC8922990</ArticleId><ArticleId IdType="pubmed">34224870</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigfrid L, Drake TM, Pauley E, Jesudason EC, Olliaro P, Lim WS, et al. . Long Covid in adults discharged from UK hospitals after Covid-19: A prospective, multicentre cohort study using the ISARIC WHO Clinical Characterization Protocol. Lancet regional Health. (2021) 8. doi:&#xa0;10.1016/J.LANEPE.2021.100186</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.LANEPE.2021.100186</ArticleId><ArticleId IdType="pmc">PMC8343377</ArticleId><ArticleId IdType="pubmed">34386785</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelutti M, Furlanis G, Stella AB, Bellavita G, Frezza N, Torresin G, et al. . Sex-dependent characteristics of Neuro-Long-COVID: Data from a dedicated neurology ambulatory service. J Neurol Sci. (2022) 441. doi:&#xa0;10.1016/J.JNS.2022.120355</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.JNS.2022.120355</ArticleId><ArticleId IdType="pmc">PMC9328838</ArticleId><ArticleId IdType="pubmed">35994869</ArticleId></ArticleIdList></Reference><Reference><Citation>Sylvester SV, Rusu R, Chan B, Bellows M, O&#x2019;Keefe C, Nicholson S. Sex differences in sequelae from COVID-19 infection and in long COVID syndrome: a review. Curr Med Res Opin. (2022) 38:1391&#x2013;9. doi:&#xa0;10.1080/03007995.2022.2081454</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/03007995.2022.2081454</ArticleId><ArticleId IdType="pubmed">35726132</ArticleId></ArticleIdList></Reference><Reference><Citation>Lemogne C, Gouraud C, Pitron V, Ranque B. Why the hypothesis of psychological mechanisms in long COVID is worth considering. J Psychosom Res. (2023) 165. doi:&#xa0;10.1016/J.JPSYCHORES.2022.111135</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.JPSYCHORES.2022.111135</ArticleId><ArticleId IdType="pmc">PMC9825049</ArticleId><ArticleId IdType="pubmed">36623391</ArticleId></ArticleIdList></Reference><Reference><Citation>Charfeddine S, Hadj Amor HI, Jdidi J, Torjmen S, Kraiem S, Hammami R, et al. . Long COVID 19 syndrome: is it related to microcirculation and endothelial dysfunction? Insights from TUN-endCOV study. Front Cardiovasc Med. (2021) 8:745758/BIBTEX. doi:&#xa0;10.3389/fcvm.2021.745758</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2021.745758</ArticleId><ArticleId IdType="pmc">PMC8670225</ArticleId><ArticleId IdType="pubmed">34917659</ArticleId></ArticleIdList></Reference><Reference><Citation>Westerlind E, Palstam A, Sunnerhagen KS, Persson HC. Patterns and predictors of sick leave after Covid-19 and long Covid in a national Swedish cohort. BMC Public Health. (2021) 21. doi:&#xa0;10.1186/S12889-021-11013-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/S12889-021-11013-2</ArticleId><ArticleId IdType="pmc">PMC8164957</ArticleId><ArticleId IdType="pubmed">34059034</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart S, Newson L, Briggs TA, Grammatopoulos D, Young L, Gill P. Long COVID risk - a signal to address sex hormones and women&#x2019;s health,&#x201d; The Lancet regional health. Europe. (2021) 11. doi:&#xa0;10.1016/J.LANEPE.2021.100242</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.LANEPE.2021.100242</ArticleId><ArticleId IdType="pmc">PMC8561426</ArticleId><ArticleId IdType="pubmed">34746909</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortona E, Malorni W. Long COVID: to investigate immunological mechanisms and sex/gender related aspects as fundamental steps for tailored therapy. Eur Respir J. (2022) 59. doi:&#xa0;10.1183/13993003.02245-2021</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.02245-2021</ArticleId><ArticleId IdType="pmc">PMC8462012</ArticleId><ArticleId IdType="pubmed">34531277</ArticleId></ArticleIdList></Reference><Reference><Citation>Bucciarelli V, Nasi M, Bianco F, Seferovic J, Ivkovic V, Gallina S, et al. . Depression pandemic and cardiovascular risk in the COVID-19 era and long COVID syndrome: Gender makes a difference. Trends Cardiovasc Med. (2022) 32:12&#x2013;7. doi:&#xa0;10.1016/J.TCM.2021.09.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.TCM.2021.09.009</ArticleId><ArticleId IdType="pmc">PMC8490128</ArticleId><ArticleId IdType="pubmed">34619336</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-De-las-pe&#xf1;as C, Mart&#xed;n-Guerrero JD, Pellicer-Valero OJ, Navarro-Pardo E, G&#xf3;mez-Mayordomo V, Cuadrado ML, et al. . Female sex is a risk factor associated with long-term post-COVID related-symptoms but not with COVID-19 symptoms: the LONG-COVID-EXP-CM multicenter study. J Clin Med. (2022) 11(2):413. doi:&#xa0;10.3390/JCM11020413</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/JCM11020413</ArticleId><ArticleId IdType="pmc">PMC8778106</ArticleId><ArticleId IdType="pubmed">35054108</ArticleId></ArticleIdList></Reference><Reference><Citation>Noval Rivas M, Porritt RA, Cheng MH, Bahar I, Arditi M. Multisystem inflammatory syndrome in children and long COVID: the SARS-coV-2 viral superantigen hypothesis. Front Immunol. (2022) 13:941009/BIBTEX. doi:&#xa0;10.3389/fimmu.2022.941009</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.941009</ArticleId><ArticleId IdType="pmc">PMC9300823</ArticleId><ArticleId IdType="pubmed">35874696</ArticleId></ArticleIdList></Reference><Reference><Citation>Notarte KI, Santos de Oliveira MH, Peligro PJ, Velasco JV, Macaranas I, Ver AT, et al. . Age, sex and previous comorbidities as risk factors not associated with SARS-coV-2 infection for long COVID-19: A systematic review and meta-analysis. J Clin Med. (2022) 11(24):7314. doi:&#xa0;10.3390/JCM11247314</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/JCM11247314</ArticleId><ArticleId IdType="pmc">PMC9787827</ArticleId><ArticleId IdType="pubmed">36555931</ArticleId></ArticleIdList></Reference><Reference><Citation>Kandemir H, B&#xfc;lb&#xfc;l GA, Kirti&#x15f; E, G&#xfc;ney S, Sanhal CY, Mendilcio&#x11f;lu II, et al. . Evaluation of long-COVID symptoms in women infected with SARS-CoV-2 during pregnancy. Int J Gynaecol Obstet. (2023) 164:148&#x2013;56. doi:&#xa0;10.1002/ijgo.14972</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ijgo.14972</ArticleId><ArticleId IdType="pubmed">37387323</ArticleId></ArticleIdList></Reference><Reference><Citation>Hui Y, Guoqiang S, Fei T, Min P, Ying G, Jing P, et al. . Clinical features and outcomes of pregnant women suspected of coronavirus disease 2019. J Infect. (2020) 81:40&#x2013;4. doi:&#xa0;10.1016/j.jinf.2020.04.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.04.003</ArticleId><ArticleId IdType="pmc">PMC7152867</ArticleId><ArticleId IdType="pubmed">32294503</ArticleId></ArticleIdList></Reference><Reference><Citation>Vasconez-Gonzales J, Fernandez-Naranjo R, Izquierdo-Condoy JS, Delgado-Moreira K, Cordovez S, Tello-De-la-Torre A, et al. . Comparative analysis of long-term self-reported COVID-19 symptoms among pregnant women. J Infect Public Heal. (2023) 16:430&#x2013;40. doi:&#xa0;10.1016/j.jiph.2023.01.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiph.2023.01.012</ArticleId><ArticleId IdType="pmc">PMC9851727</ArticleId><ArticleId IdType="pubmed">36736066</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang H, Pan Y, Chen W, Yang X, Liu B, Yuan N, et al. . Prevalence of and relevant factors for depression and anxiety symptoms among pregnant women on the eastern seaboard of China in the post-COVID-19 era: a cross-sectional study. BMC Psychiatry. (2023) 23:564. doi:&#xa0;10.1186/s12888-023-05059-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12888-023-05059-2</ArticleId><ArticleId IdType="pmc">PMC10405434</ArticleId><ArticleId IdType="pubmed">37550657</ArticleId></ArticleIdList></Reference><Reference><Citation>Stepowicz A, Wencka B, Bie&#x144;kiewicz J, Horzelski W, Grzesiak M, et al. . Stress and anxiety levels in pregnant and post-partum women during the COVID-19 pandemic. Int J Environ Res Public Health. (2020) 17:9450. doi:&#xa0;10.3390/ijerph17249450</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph17249450</ArticleId><ArticleId IdType="pmc">PMC7766953</ArticleId><ArticleId IdType="pubmed">33348568</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu F, Lin W, Liu P, Zhang M, Huang S, Chen C, et al. . Prevalence and contributory factors of anxiety and depression among pregnant women in the post-pandemic era of COVID-19 in Shenzhen, China. J Affect. Disord. (2021) 291:243&#x2013;51. doi:&#xa0;10.1016/j.jad.2021.05.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2021.05.014</ArticleId><ArticleId IdType="pmc">PMC9754805</ArticleId><ArticleId IdType="pubmed">34051531</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimmermann P, Pittet LF, Curtis N. How common is long COVID in children and adolescents? Pediatr Infect Dis J. (2021) 40:e482. doi:&#xa0;10.1097/INF.0000000000003328</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000003328</ArticleId><ArticleId IdType="pmc">PMC8575095</ArticleId><ArticleId IdType="pubmed">34870392</ArticleId></ArticleIdList></Reference><Reference><Citation>Haddad A, Janda A, Renk H, Stich M, Frieh P, Kaier K, et al. . Long COVID symptoms in exposed and infected children, adolescents and their parents one year after SARS-CoV-2 infection: A prospective observational cohort study. EBioMedicine. (2022) 84. doi:&#xa0;10.1016/J.EBIOM.2022.104245</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.EBIOM.2022.104245</ArticleId><ArticleId IdType="pmc">PMC9495281</ArticleId><ArticleId IdType="pubmed">36155957</ArticleId></ArticleIdList></Reference><Reference><Citation>Kikkenborg Berg S, Palm P, Nygaard U, Bundgaard H, Schmidt Petersen MN, Rosenkilde s, et al. . Long COVID symptoms in SARS-CoV-2-positive children aged 0&#x2013;14 years and matched controls in Denmark (LongCOVIDKidsDK): a national, cross-sectional study. Lancet Child Adolesc Health. (2022) 6:614&#x2013;23. doi:&#xa0;10.1016/S2352-4642(22)00154-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(22)00154-7</ArticleId><ArticleId IdType="pmc">PMC9221683</ArticleId><ArticleId IdType="pubmed">35752194</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Ayuzo del Valle NC, Perelman C, Sepulveda R, Rebolledo Pa, et al. . Long-COVID in children and adolescents: a systematic review and meta-analyses. Sci Rep. (2022) 12. doi:&#xa0;10.1038/S41598-022-13495-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/S41598-022-13495-5</ArticleId><ArticleId IdType="pmc">PMC9226045</ArticleId><ArticleId IdType="pubmed">35739136</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Zhou Y, Ma J, Zhang Q, Shao J, Liang S, et al. . The long-term health outcomes, pathophysiological mechanisms and multidisciplinary management of long COVID. Sig Transduct Target Ther. (2023) 8:416. doi:&#xa0;10.1038/s41392-023-01640-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-023-01640-z</ArticleId><ArticleId IdType="pmc">PMC10618229</ArticleId><ArticleId IdType="pubmed">37907497</ArticleId></ArticleIdList></Reference><Reference><Citation>Fainardi V, Meoli A, Chiopris G, Motta M, Skenderaj K, Grandinetti R, et al. . Long COVID in children and adolescents. Life (Basel). (2022) 12(2):285. doi:&#xa0;10.3390/LIFE12020285</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/LIFE12020285</ArticleId><ArticleId IdType="pmc">PMC8876679</ArticleId><ArticleId IdType="pubmed">35207572</ArticleId></ArticleIdList></Reference><Reference><Citation>Borch L, Holm M, Knudsen M, Ellermann-Eriksen S, Hagstroem S. Long COVID symptoms and duration in SARS-CoV-2 positive children - a nationwide cohort study. Eur J Pediatr. (2022) 181:1597&#x2013;607. doi:&#xa0;10.1007/s00431-021-04345-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-021-04345-z</ArticleId><ArticleId IdType="pmc">PMC8742700</ArticleId><ArticleId IdType="pubmed">35000003</ArticleId></ArticleIdList></Reference><Reference><Citation>Kikkenborg Berg S, Nielsen SD, Nygaard U, Bundgaard H, Palm P, Rotvig C, et al. . Long COVID symptoms in SARS-CoV-2-positive adolescents and matched controls (LongCOVIDKidsDK): a national, cross-sectional study. Lancet Child Adolesc Health. (2022) 6:240&#x2013;8. doi:&#xa0;10.1016/S2352-4642(22)00004-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(22)00004-9</ArticleId><ArticleId IdType="pmc">PMC8820960</ArticleId><ArticleId IdType="pubmed">35143771</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephenson T, Allin B, Nugawela MD, Rojas N, Dalrymple E, Pereira SP, et al. . Long COVID (post-COVID-19 condition) in children: a modified Delphi process. Arch Dis Child. (2022) 107:674&#x2013;80. doi:&#xa0;10.1136/ARCHDISCHILD-2021-323624</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ARCHDISCHILD-2021-323624</ArticleId><ArticleId IdType="pmc">PMC8983414</ArticleId><ArticleId IdType="pubmed">35365499</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D, Pujol FE, Munblit D, Pata D, McFarland S, Simpson FK. Clinical characteristics, activity levels and mental health problems in children with long coronavirus disease: a survey of 510 children. Future Microbiol. (2022) 17:577&#x2013;88. doi:&#xa0;10.2217/FMB-2021-0285</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/FMB-2021-0285</ArticleId><ArticleId IdType="pmc">PMC9248023</ArticleId><ArticleId IdType="pubmed">35360923</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashkenazi-Hoffnung L, Shmueli E, Ehrlich S, Ziv A, Bar-On O, Birk E, et al. . Long COVID in children: observations from a designated pediatric clinic. Pediatr Infect Dis J. (2021) 40:E509&#x2013;11. doi:&#xa0;10.1097/INF.0000000000003285</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000003285</ArticleId><ArticleId IdType="pmc">PMC8575093</ArticleId><ArticleId IdType="pubmed">34371507</ArticleId></ArticleIdList></Reference><Reference><Citation>Esposito S, Principi N, Azzari C, Cardinale F, Di Mauro G, Galli L, et al. . Italian intersociety consensus on management of long covid in children. Ital J Pediatr. (2022) 48. doi:&#xa0;10.1186/S13052-022-01233-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/S13052-022-01233-6</ArticleId><ArticleId IdType="pmc">PMC8905554</ArticleId><ArticleId IdType="pubmed">35264214</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D, Munblit D, De Rose C, Sinatti D, Ricchiuto A, Carfi A, et al. . Preliminary evidence on long COVID in children. Acta Paediatr. (2021) 110:2208&#x2013;11. doi:&#xa0;10.1111/APA.15870</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/APA.15870</ArticleId><ArticleId IdType="pmc">PMC8251440</ArticleId><ArticleId IdType="pubmed">33835507</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephenson T, Pinto Pereira SM, Roz Shafran R, de Stavola BL, Rojas N, McOwat K, et al. . Physical and mental health 3 months after SARS-CoV-2 infection (long COVID) among adolescents in England (CLoCk): a national matched cohort study. Lancet Child Adolesc Health. (2022) 6:230&#x2013;9. doi:&#xa0;10.1016/S2352-4642(22)00022-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(22)00022-0</ArticleId><ArticleId IdType="pmc">PMC8820961</ArticleId><ArticleId IdType="pubmed">35143770</ArticleId></ArticleIdList></Reference><Reference><Citation>Adab P, Haroon S, O&#x2019;Hara ME, Jordan RE. Comorbidities and covid-19. BMJ. (2022) 377:o1431. doi:&#xa0;10.1136/BMJ.O1431</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/BMJ.O1431</ArticleId><ArticleId IdType="pubmed">35705219</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal AD, VanElzakker MB. Long COVID or post-acute sequelae of COVID-19 (PASC): an overview of biological factors that may contribute to persistent symptoms. Front Microbiol. (2021) 12:698169/BIBTEX. doi:&#xa0;10.3389/fmicb.2021.698169</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.698169</ArticleId><ArticleId IdType="pmc">PMC8260991</ArticleId><ArticleId IdType="pubmed">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson EJ, Williams DM, Walker AJ, Mitchell RE, Niedzwiedz CL, Yang TC, et al. . Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records. Nat Commun. (2022) 13:1&#x2013;11. doi:&#xa0;10.1038/s41467-022-30836-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-30836-0</ArticleId><ArticleId IdType="pmc">PMC9240035</ArticleId><ArticleId IdType="pubmed">35764621</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, et al. . Attributes and predictors of long COVID. Nat Med. (2021) 27:626&#x2013;31. doi:&#xa0;10.1038/s41591-021-01292-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C, Haupert SR, Zimmermann L, Shi X, Fritsche LG, Mukherjee B. Global prevalence of post-coronavirus disease 2019 (COVID-19) condition or long COVID: A meta-analysis and systematic review. J Infect Dis. (2022) 226:1593&#x2013;607. doi:&#xa0;10.1093/INFDIS/JIAC136</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/INFDIS/JIAC136</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Khunti K, Davies MJ, Kosiborod MN, Nauck MA. Long COVID - metabolic risk factors and novel therapeutic management. Nat Rev Endocrinol. (2021) 17:379&#x2013;80. doi:&#xa0;10.1038/S41574-021-00495-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/S41574-021-00495-0</ArticleId><ArticleId IdType="pmc">PMC8054121</ArticleId><ArticleId IdType="pubmed">33875855</ArticleId></ArticleIdList></Reference><Reference><Citation>Frontera JA, Yang D, Lewis A, Patel P, Medicherla C, Arena V, et al. . A prospective study of long-term outcomes among hospitalized COVID-19 patients with and without neurological complications. J Neurol Sci. (2021) 426. doi:&#xa0;10.1016/J.JNS.2021.117486</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.JNS.2021.117486</ArticleId><ArticleId IdType="pmc">PMC8113108</ArticleId><ArticleId IdType="pubmed">34000678</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabrera Martimbianco AL, Pacheco RL, Bagattini &#xc2;.M, Riera R. Frequency, signs and symptoms, and criteria adopted for long COVID-19: A systematic review. Int J Clin Pract. (2021) 75(10):e14357. doi:&#xa0;10.1111/IJCP.14357</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/IJCP.14357</ArticleId><ArticleId IdType="pmc">PMC8236920</ArticleId><ArticleId IdType="pubmed">33977626</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivera-Izquierdo M, L&#xe1;inez-Ramos-Bossini AJ, de Alba IGF, Ortiz-Gonz&#xe1;lez-Serna R, Serrano-Ortiz A, Fern&#xe1;ndez-Mart&#xed;nez NF, et al. . Long COVID 12 months after discharge: persistent symptoms in patients hospitalized due to COVID-19 and patients hospitalized due to other causes-a multicentre cohort study. BMC Med. (2022) 20:92. doi:&#xa0;10.1186/S12916-022-02292-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/S12916-022-02292-6</ArticleId><ArticleId IdType="pmc">PMC8863509</ArticleId><ArticleId IdType="pubmed">35193574</ArticleId></ArticleIdList></Reference><Reference><Citation>Florencio LL, Fern&#xe1;ndez-de-las-Pe&#xf1;as C. Long COVID: systemic inflammation and obesity as therapeutic targets. Lancet Respir Med. (2022) 10:726&#x2013;7. doi:&#xa0;10.1016/S2213-2600(22)00159-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00159-X</ArticleId><ArticleId IdType="pmc">PMC9034853</ArticleId><ArticleId IdType="pubmed">35472305</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Mahoney LL, Routen A, Gillies C, Ekezie W, Welford A, Zhang A, et al. . The prevalence and long-term health effects of Long Covid among hospitalized and non-hospitalized populations: A systematic review and meta-analysis. E Clin Med. (2022) 55. doi:&#xa0;10.1016/J.ECLINM.2022.101762</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.ECLINM.2022.101762</ArticleId><ArticleId IdType="pmc">PMC9714474</ArticleId><ArticleId IdType="pubmed">36474804</ArticleId></ArticleIdList></Reference><Reference><Citation>Estiri H, Strasser ZH, Brat GA, Semenov YR, et al. . Evolving phenotypes of non-hospitalized patients that indicate long covid. medRxiv. (2021). doi:&#xa0;10.1101/2021.04.25.21255923</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.04.25.21255923</ArticleId><ArticleId IdType="pmc">PMC8474909</ArticleId><ArticleId IdType="pubmed">34565368</ArticleId></ArticleIdList></Reference><Reference><Citation>Guedes AR, Oliveira MS, Tavares BM, Luna-Muschi A, dos Santos Lazari C, Montal AC, et al. . Reinfection rate in a cohort of healthcare workers over 2 years of the COVID-19 pandemic. Sci Rep. (2023) 13:712. doi:&#xa0;10.1038/s41598-022-25908-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-25908-6</ArticleId><ArticleId IdType="pmc">PMC9837751</ArticleId><ArticleId IdType="pubmed">36639411</ArticleId></ArticleIdList></Reference><Reference><Citation>Boufidou F, Medi&#x107; S, Lampropoulou V, Siafakas N, Tsakris A, Anastassopoulou C. SARS-coV-2 reinfections and long COVID in the post-omicron phase of the pandemic. Int J Mol Sci. (2023) 24:12962. doi:&#xa0;10.3390/ijms241612962</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms241612962</ArticleId><ArticleId IdType="pmc">PMC10454552</ArticleId><ArticleId IdType="pubmed">37629143</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosworth ML, Shenhuy B, Walker S, Nafilyan V, Alwan NA, O&#x2019;Hara Me, et al. . Risk of new-onset Long Covid following reinfection with SARS-CoV-2: community-based cohort study. medRxiv. (2023). doi:&#xa0;10.1101/2023.04.13.23288522</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2023.04.13.23288522</ArticleId><ArticleId IdType="pmc">PMC10633780</ArticleId><ArticleId IdType="pubmed">37953820</ArticleId></ArticleIdList></Reference><Reference><Citation>Cegolon L, Mauro M, Sansone D, Tassinari A, Gobba FM, Modenese A, et al. . A multi-center study investigating long COVID-19 in healthcare workers from north-eastern Italy: prevalence, risk factors and the impact of pre-existing humoral immunity&#x2014;ORCHESTRA project. Vaccines. (2023) 11:1769. doi:&#xa0;10.3390/vaccines11121769</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines11121769</ArticleId><ArticleId IdType="pmc">PMC10747427</ArticleId><ArticleId IdType="pubmed">38140174</ArticleId></ArticleIdList></Reference><Reference><Citation>Kenny G, McCann K, O&#x2019;Brien C, O&#x2019;Broin C, Tinago W, Yousif O, et al. . Impact of vaccination and variants of concern on long COVID clinical phenotypes. BMC Inf Dis. (2023) 23:804. doi:&#xa0;10.1186/s12879-023-08783-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-023-08783-y</ArticleId><ArticleId IdType="pmc">PMC10655269</ArticleId><ArticleId IdType="pubmed">37974068</ArticleId></ArticleIdList></Reference><Reference><Citation>Canas LS, Molteni E, Deng J, Sudre CH, Murray B, Kerfoot E, et al. . Profiling post-COVID-19 condition across different variants of SARS-CoV-2: a prospective longitudinal study in unvaccinated wild-type, unvaccinated alpha-variant, and vaccinated delta-variant populations. Lancet. (2023) 5:441&#x2013;34. doi:&#xa0;10.1016/S2589-7500(23)00056-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2589-7500(23)00056-0</ArticleId><ArticleId IdType="pmc">PMC10187990</ArticleId><ArticleId IdType="pubmed">37202336</ArticleId></ArticleIdList></Reference><Reference><Citation>Diexer S, Klee B, Gottschick C, Xu C, Broda A, Purschke O, et al. . Association between virus variants, vaccination, previous infections, and post-COVID-19 risk. I J Inf Diseas. (2023) 136:14&#x2013;21. doi:&#xa0;10.1016/j.ijid.2023.08.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2023.08.019</ArticleId><ArticleId IdType="pubmed">37634619</ArticleId></ArticleIdList></Reference><Reference><Citation>Perlis RH, Santillana M, Ognyanova K, Safarpour A, Trujillo KL, Simonson MD, et al. . Prevalence and correlates of long COVID symptoms among US adults. JAMA. (2022) 5(10):e2238804. doi:&#xa0;10.1001/jamanetworkopen.2022.38804</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.38804</ArticleId><ArticleId IdType="pmc">PMC9614581</ArticleId><ArticleId IdType="pubmed">36301542</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C, Notarte KI, Peligro PJ, Velasco JV, Ocampo MJ, Henry BM, et al. . Long-COVID symptoms in individuals infected with different SARS-coV-2 variants of concern: A systematic review of the literature. Viruses. (2022) 14:2629. doi:&#xa0;10.3390/v14122629</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14122629</ArticleId><ArticleId IdType="pmc">PMC9785120</ArticleId><ArticleId IdType="pubmed">36560633</ArticleId></ArticleIdList></Reference><Reference><Citation>Azzolini E, Levi R, Sarti R, Pozzi C, Mollura M, Mantovani A, et al. . Association between BNT162b2 vaccination and long COVID after infections not requiring hospitalization in health care workers. JAMA. (2022) 328:676&#x2013;8. doi:&#xa0;10.1001/JAMA.2022.11691</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/JAMA.2022.11691</ArticleId><ArticleId IdType="pmc">PMC9250078</ArticleId><ArticleId IdType="pubmed">35796131</ArticleId></ArticleIdList></Reference><Reference><Citation>Ledford H. How common is long COVID? Why studies give different answers. Nature. (2022) 606:852&#x2013;3. doi:&#xa0;10.1038/D41586-022-01702-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/D41586-022-01702-2</ArticleId><ArticleId IdType="pubmed">35725828</ArticleId></ArticleIdList></Reference><Reference><Citation>Strain WD, Sherwood O, Banerjee A, van der Togt V, Hishmeh L, Rossman J. The impact of COVID vaccination on symptoms of long COVID: an international survey of people with lived experience of long COVID. Vaccines (Basel). (2022) 10(5):652. doi:&#xa0;10.3390/VACCINES10050652</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/VACCINES10050652</ArticleId><ArticleId IdType="pmc">PMC9146071</ArticleId><ArticleId IdType="pubmed">35632408</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao P, Liu J, Liu M. Effect of COVID-19 vaccines on reducing the risk of long COVID in the real world: A systematic review and meta-analysis. Int J Environ Res Public Health. (2022) 19:12422. doi:&#xa0;10.3390/IJERPH191912422</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/IJERPH191912422</ArticleId><ArticleId IdType="pmc">PMC9566528</ArticleId><ArticleId IdType="pubmed">36231717</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q, Qin C, Liu M, Liu J. Effectiveness and safety of SARS-CoV-2 vaccine in real-world studies: a systematic review and meta-analysis. Infect Dis Poverty. (2021) 10:132. doi:&#xa0;10.1186/S40249-021-00915-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/S40249-021-00915-3</ArticleId><ArticleId IdType="pmc">PMC8590867</ArticleId><ArticleId IdType="pubmed">34776011</ArticleId></ArticleIdList></Reference><Reference><Citation>Notarte KI, Catahay JA, Velasco JV, Pastrana A, Ver AT, Pangilinan FC, et al. . Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: A systematic review. E Clin Med. (2022) 53. doi:&#xa0;10.1016/J.ECLINM.2022.101624</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.ECLINM.2022.101624</ArticleId><ArticleId IdType="pmc">PMC9417563</ArticleId><ArticleId IdType="pubmed">36051247</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D, Bermingham C, Pouwels KB, Glickman M, Nafilyan V, Zaccardi F, et al. . Trajectory of long covid symptoms after covid-19 vaccination: community-based cohort study. BMJ. (2022) 377:2022. doi:&#xa0;10.1136/BMJ-2021-069676</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/BMJ-2021-069676</ArticleId><ArticleId IdType="pmc">PMC9115603</ArticleId><ArticleId IdType="pubmed">35584816</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T, Sivan M, Delaney B, Evans R, Milne R. Long covid&#x2014;an update for primary care. BMJ. (2022) 378:e072117. doi:&#xa0;10.1136/BMJ-2022-072117</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/BMJ-2022-072117</ArticleId><ArticleId IdType="pubmed">36137612</ArticleId></ArticleIdList></Reference><Reference><Citation>Wise J. Covid-19: Long covid risk is lower with omicron than delta, researchers find. BMJ. (2022) 377:o1500. doi:&#xa0;10.1136/BMJ.O1500</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/BMJ.O1500</ArticleId><ArticleId IdType="pubmed">35714995</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xf8;raas A, Kalleberg KA, Dahl JA, S&#xf8;raas CL, Myklebust TA, Axelsen E, et al. . Persisting symptoms three to eight months after non-hospitalized COVID-19, a prospective cohort study. PloS One. (2021) 16(8):e0256142. doi:&#xa0;10.1371/JOURNAL.PONE.0256142</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/JOURNAL.PONE.0256142</ArticleId><ArticleId IdType="pmc">PMC8389372</ArticleId><ArticleId IdType="pubmed">34437579</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold D, Milne A, Samms E, Stadon L, Maskell N, Hamilton F. Are vaccines safe in patients with Long COVID? A prospective observational study. medRxiv. (2021). doi:&#xa0;10.1101/2021.03.11.21253225</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.03.11.21253225</ArticleId></ArticleIdList></Reference><Reference><Citation>Yelin D, Margalit I, Yahav D, Runold M, Bruchfeld J. Long COVID-19-it&#x2019;s not over until? Clin Microbiol Infect. (2021) 27:506&#x2013;8. doi:&#xa0;10.1016/J.CMI.2020.12.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.CMI.2020.12.001</ArticleId><ArticleId IdType="pmc">PMC7832095</ArticleId><ArticleId IdType="pubmed">33316400</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, Deeks SG. Early clues regarding the pathogenesis of long-COVID. Trends Immunol. (2022) 43:268&#x2013;70. doi:&#xa0;10.1016/J.IT.2022.02.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.IT.2022.02.008</ArticleId><ArticleId IdType="pmc">PMC8901423</ArticleId><ArticleId IdType="pubmed">35272932</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran VT, Perrodeau E, Saldanha J, Pane I, Ravaud P. Efficacy of COVID-19 vaccination on the symptoms of patients with long COVID: a target trial emulation using data from the ComPaRe e-cohort in France. (2022). doi:&#xa0;10.21203/RS.3.RS-1350429/V1</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/RS.3.RS-1350429/V1</ArticleId><ArticleId IdType="pmc">PMC9978748</ArticleId><ArticleId IdType="pubmed">36910458</ArticleId></ArticleIdList></Reference><Reference><Citation>Ekstr&#xf6;m S, Andersson N, L&#xf6;vquist A, Lauber A, Georgelis A, Kull I, et al. . COVID-19 among young adults in Sweden: self-reported long-term symptoms and associated factors. Scand J Public Health. (2022) 50:85. doi:&#xa0;10.1177/14034948211025425</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/14034948211025425</ArticleId><ArticleId IdType="pmc">PMC8808012</ArticleId><ArticleId IdType="pubmed">34148461</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright J, Astill SL, Sivan M. The relationship between physical activity and long COVID: A cross-sectional study. Int J Environ Res Public Health. (2022) 19(9):5093. doi:&#xa0;10.3390/IJERPH19095093</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/IJERPH19095093</ArticleId><ArticleId IdType="pmc">PMC9105041</ArticleId><ArticleId IdType="pubmed">35564488</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Z, Ekstr&#xf6;m S, Bellander T, Ljungman P, Pershagen G, Eneroth K, et al. . Ambient air pollution exposure linked to long COVID among young adults: a nested survey in a population-based cohort in Sweden. Lancet Regional Health - Europe. (2023) 28. doi:&#xa0;10.1016/j.lanepe.2023.100608</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2023.100608</ArticleId><ArticleId IdType="pmc">PMC9989696</ArticleId><ArticleId IdType="pubmed">37131862</ArticleId></ArticleIdList></Reference><Reference><Citation>Brussow H, Timmis K. COVID-19: long covid and its societal consequences. Environ Microbiol. (2021) 23:4077&#x2013;91. doi:&#xa0;10.1111/1462-2920.15634</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1462-2920.15634</ArticleId><ArticleId IdType="pubmed">34110078</ArticleId></ArticleIdList></Reference><Reference><Citation>Jassat W, Reyes LF, Munblit D, Caoili J, Bozza F, Hashmi M, et al. . Long COVID in low-income and middle-income countries: the hidden public health crisis. Lancet. (2023) 402:1115&#x2013;7. doi:&#xa0;10.1016/S0140-6736(23)01685-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(23)01685-9</ArticleId><ArticleId IdType="pubmed">37652071</ArticleId></ArticleIdList></Reference><Reference><Citation>Nyasulu PS, Tamuzi JL, Erasmus RT. Burden, causation, and particularities of Long COVID in African populations: A rapid systematic review. IJID Reg. (2023) 8:137&#x2013;44. doi:&#xa0;10.1016/j.ijregi.2023.08.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijregi.2023.08.004</ArticleId><ArticleId IdType="pmc">PMC10477483</ArticleId><ArticleId IdType="pubmed">37674565</ArticleId></ArticleIdList></Reference><Reference><Citation>Malliarou M, Gagamanou A, Bouletis A, Tzenetidis V, Papathanasiou I, Theodoropoulou M, et al. . COVID-19 pandemic and health and social inequalities worldwide: impact and response measures in Greece. Adv Exp Med Biol. (2023) 1425:393&#x2013;9. doi:&#xa0;10.1007/978-3-031-31986-0_38</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-031-31986-0_38</ArticleId><ArticleId IdType="pubmed">37581813</ArticleId></ArticleIdList></Reference><Reference><Citation>Available online at: https://iris.who.int/bitstream/handle/10665/341050/WHO-EURO-2021-2410-42165-58100-eng.pdf?sequence=1 (Accessed 4th of January, 2024).</Citation></Reference><Reference><Citation>Baraniuk C. Covid-19: How Europe is approaching long covid. BMJ. (2022) 376:o158. doi:&#xa0;10.1136/BMJ.O158</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/BMJ.O158</ArticleId><ArticleId IdType="pubmed">35058230</ArticleId></ArticleIdList></Reference><Reference><Citation>Verger A, Kas A, Dudouet P, Goehringer F, Salmon-Ceron D, Guedj E. Visual interpretation of brain hypometabolism related to neurological long COVID: a French multicentric experience. Eur J Nucl Med Mol Imaging. (2022) 49:3197&#x2013;202. doi:&#xa0;10.1007/S00259-022-05753-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/S00259-022-05753-5</ArticleId><ArticleId IdType="pmc">PMC8941296</ArticleId><ArticleId IdType="pubmed">35320385</ArticleId></ArticleIdList></Reference><Reference><Citation>
Lorenz-Dant K. Germany and the COVID-19 long-term care situation. LTCcovid, International Long Term Care Policy Network, CPEC-LSE (2020). Available at: https://ltccovid.org/wp-content/uploads/2020/05/Germany_LTC_COVID-19-26-May-2020.pdf.</Citation></Reference><Reference><Citation>Umakanthan S, Monice M, Mehboob S, Jones CL, Lawrence S. Post-acute (long) COVID-19 quality of life: validation of the German version of (PAC19QoL) instrument. Front Public Health. (2023) 11:1163360. doi:&#xa0;10.3389/FPUBH.2023.1163360</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FPUBH.2023.1163360</ArticleId><ArticleId IdType="pmc">PMC10349205</ArticleId><ArticleId IdType="pubmed">37457286</ArticleId></ArticleIdList></Reference><Reference><Citation>Bahmer T, Borzikowsky C, Lieb W, Horn A, Krist L, Fricke J, et al. . Severity, predictors and clinical correlates of Post-COVID syndrome (PCS) in Germany: A prospective, multi-center, population-based cohort study. EClinicalMedicine. (2022) 51. doi:&#xa0;10.1016/J.ECLINM.2022.101549</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.ECLINM.2022.101549</ArticleId><ArticleId IdType="pmc">PMC9289961</ArticleId><ArticleId IdType="pubmed">35875815</ArticleId></ArticleIdList></Reference><Reference><Citation>Landi F, Gremese E, Bernabei R, Fantoni M, Gasbarrini A, Settanni CR, et al. . Post-COVID-19 global health strategies: the need for an interdisciplinary approach. Aging Clin Exp Res. (2020) 32:1613&#x2013;20. doi:&#xa0;10.1007/S40520-020-01616-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/S40520-020-01616-X</ArticleId><ArticleId IdType="pmc">PMC7287410</ArticleId><ArticleId IdType="pubmed">32529595</ArticleId></ArticleIdList></Reference><Reference><Citation>Fissi S, Gori E, Romolini A. Social media government communication and stakeholder engagement in the era of Covid-19: evidence from Italy. Int J Public Sector Manage. (2022) 35:276&#x2013;93. doi:&#xa0;10.1108/IJPSM-06-2021-0145/FULL/PDF</Citation><ArticleIdList><ArticleId IdType="doi">10.1108/IJPSM-06-2021-0145/FULL/PDF</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruiu ML. Mismanagement of Covid-19: lessons learned from Italy. J Risk Res. (2020) 23:1007&#x2013;20. doi:&#xa0;10.1080/13669877.2020.1758755</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13669877.2020.1758755</ArticleId></ArticleIdList></Reference><Reference><Citation>
Nordic solidarity and covid-19. Available online at: https://ams.hi.is/en/publication/83/ (Accessed Aug. 05, 2023).</Citation></Reference><Reference><Citation>Greve B, Blomquist P, Hvinden B, van Gerven M. Nordic welfare states-still standing or changed by the COVID-19 crisis? Soc Policy Adm. (2021) 55:295&#x2013;311. doi:&#xa0;10.1111/SPOL.12675</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/SPOL.12675</ArticleId><ArticleId IdType="pmc">PMC7753633</ArticleId><ArticleId IdType="pubmed">33362319</ArticleId></ArticleIdList></Reference><Reference><Citation>Saunes IS, Vrangb&#xe6;k K, Byrkjeflot H, Jervelund SS, Birk HO, Tynkkynen LK, et al. . Nordic responses to Covid-19: Governance and policy measures in the early phases of the pandemic. Health Policy. (2022) 126:418&#x2013;26. doi:&#xa0;10.1016/J.HEALTHPOL.2021.08.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.HEALTHPOL.2021.08.011</ArticleId><ArticleId IdType="pmc">PMC8418563</ArticleId><ArticleId IdType="pubmed">34629202</ArticleId></ArticleIdList></Reference><Reference><Citation>de la Porte C, Jensen MD, Kvist J. Going Nordic&#x2014;Can the Nordic model tackle grand challenges and be a beacon to follow? Regul Gov. (2023) 17:595&#x2013;607. doi:&#xa0;10.1111/REGO.12494</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/REGO.12494</ArticleId></ArticleIdList></Reference><Reference><Citation>Christensen T, Jensen MD, Kluth M, Kristinsson GH, Lynggaard K, L&#xe6;greid P, et al. . The Nordic governments&#x2019; responses to the Covid-19 pandemic: A comparative study of variation in governance arrangements and regulatory instruments. Regul Gov. (2022) 17(3):658&#x2013;76. doi:&#xa0;10.1111/REGO.12497</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/REGO.12497</ArticleId><ArticleId IdType="pmc">PMC9538262</ArticleId><ArticleId IdType="pubmed">36246344</ArticleId></ArticleIdList></Reference><Reference><Citation>Sis&#xf3;-Almirall A, Brito-Zer&#xf3;n P, Conangla Ferr&#xed;n L, Kostov B, Moragas Moreno A, Mestres J, et al. . Long covid-19: proposed primary care clinical guidelines for diagnosis and disease management. Int J Environ Res Public Health. (2021) 18(8):4350. doi:&#xa0;10.3390/IJERPH18084350</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/IJERPH18084350</ArticleId><ArticleId IdType="pmc">PMC8073248</ArticleId><ArticleId IdType="pubmed">33923972</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C, Rodr&#xed;guez-Jim&#xe9;nez J, Moro-L&#xf3;pez-Menchero P, Cancela-Cilleruelo I, Pardo-Hern&#xe1;ndez A, Hern&#xe1;ndez-Barrera V, et al. . Psychometric properties of the Spanish version of the EuroQol-5D-5L in previously hospitalized COVID-19 survivors with long COVID. Sci Rep. (2022) 12. doi:&#xa0;10.1038/S41598-022-17033-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/S41598-022-17033-1</ArticleId><ArticleId IdType="pmc">PMC9307967</ArticleId><ArticleId IdType="pubmed">35871259</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe9;rez-Gonz&#xe1;lez A, Ara&#xfa;jo-Ameijeiras A, Fern&#xe1;ndez-Villar A, Crespo M, Poveda E, Cohort COVID-19 of the Galicia Sur Health Research Institute . Long COVID in hospitalized and non-hospitalized patients in a large cohort in Northwest Spain, a prospective cohort study. Sci Rep. (2022) 12(1):3369. doi:&#xa0;10.1038/S41598-022-07414-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/S41598-022-07414-X</ArticleId><ArticleId IdType="pmc">PMC8888560</ArticleId><ArticleId IdType="pubmed">35233035</ArticleId></ArticleIdList></Reference><Reference><Citation>Antoniou KM, Vasarmidi E, Russell AM, Andrejak C, Crestani B, Delcroix M, et al. . European Respiratory Society statement on long COVID follow-up. Eur Respir J. (2022) 60. doi:&#xa0;10.1183/13993003.02174-2021</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.02174-2021</ArticleId><ArticleId IdType="pmc">PMC9349784</ArticleId><ArticleId IdType="pubmed">35144991</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladds E, Rushforth AA, Wieringa BS, Taylor CS, Rayner DC, Husain EL, et al. . Developing services for long COVID: lessons from a study of wounded healers. Clin Med (Lond). (2021) 21:59&#x2013;65. doi:&#xa0;10.7861/CLINMED.2020-0962</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/CLINMED.2020-0962</ArticleId><ArticleId IdType="pmc">PMC7850205</ArticleId><ArticleId IdType="pubmed">33479069</ArticleId></ArticleIdList></Reference><Reference><Citation>Routen A, O&#x2019;Mahoney L, Ayoubkhani D, Banerjee A, Brightling C, Calvert M, et al. . Understanding and tracking the impact of long COVID in the United Kingdom. Nat Med. (2022) 28:11&#x2013;5. doi:&#xa0;10.1038/S41591-021-01591-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/S41591-021-01591-4</ArticleId><ArticleId IdType="pubmed">34811549</ArticleId></ArticleIdList></Reference><Reference><Citation>Cutler DM. The costs of long COVID. JAMA Health Forum. (2022) 3(5):e221809. doi:&#xa0;10.1001/JAMAHEALTHFORUM.2022.1809</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/JAMAHEALTHFORUM.2022.1809</ArticleId><ArticleId IdType="pubmed">36219031</ArticleId></ArticleIdList></Reference><Reference><Citation>
HHS announces the formation of the office of long COVID research and practice and launch of long COVID clinical trials through the RECOVER initiative | HHS.gov. Available online at: https://www.hhs.gov/about/news/2023/07/31/hhs-announces-formation-office-long-covid-research-practice-launch-long-covid-clinical-trials-through-recover-initiative.html (Accessed Aug. 05, 2023).</Citation></Reference><Reference><Citation>Hopkins Tanne J. Covid-19: US agency launches raft of clinical trials of treatments for long covid. BMJ. (2023) 382:1797. doi:&#xa0;10.1136/bmj.p1797</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.p1797</ArticleId><ArticleId IdType="pubmed">37536722</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman B, Bluemke DA, L&#xfc;scher TF, Neubauer S. Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus. Eur Heart J. (2022) 43:1157&#x2013;72. doi:&#xa0;10.1093/EURHEARTJ/EHAC031</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/EURHEARTJ/EHAC031</ArticleId><ArticleId IdType="pmc">PMC8903393</ArticleId><ArticleId IdType="pubmed">35176758</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahamed J, Laurence J. Long COVID endotheliopathy: hypothesized mechanisms and potential therapeutic approaches. J Clin Invest. (2022) 132(15):e161167. doi:&#xa0;10.1172/JCI161167</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI161167</ArticleId><ArticleId IdType="pmc">PMC9337829</ArticleId><ArticleId IdType="pubmed">35912863</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefanou MI, Palaiodimou L, Bakola E, Smyrnis N, Papadopoulou M, Paraskevas GP, et al. . Neurological manifestations of long-COVID syndrome: a narrative review. Ther Adv Chronic Dis. (2022) 13:20406223221076890. doi:&#xa0;10.1177/20406223221076890</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/20406223221076890</ArticleId><ArticleId IdType="pmc">PMC8859684</ArticleId><ArticleId IdType="pubmed">35198136</ArticleId></ArticleIdList></Reference><Reference><Citation>DeMars J, Brown DA, Angelidis I, Jones F, McGuire F, O&#x2019;Brien KK, et al. . What is safe long COVID rehabilitation? J Occup Rehabil. (2023) 33:227&#x2013;30. doi:&#xa0;10.1007/S10926-022-10075-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/S10926-022-10075-2</ArticleId><ArticleId IdType="pmc">PMC9628454</ArticleId><ArticleId IdType="pubmed">36315323</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbara C, Clavario P, De Marzo V, Lotti R, Guglielmi G, Porcile A, et al. . Effects of exercise rehabilitation in patients with long coronavirus disease 2019. Eur J Prev Cardiol. (2022) 29:E258&#x2013;60. doi:&#xa0;10.1093/EURJPC/ZWAC019</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/EURJPC/ZWAC019</ArticleId><ArticleId IdType="pmc">PMC8807301</ArticleId><ArticleId IdType="pubmed">35078233</ArticleId></ArticleIdList></Reference><Reference><Citation>Nopp S, Moik F, Klok FA, Gattinger D, Petrovic M, Vonbank K, et al. . Outpatient pulmonary rehabilitation in patients with long COVID improves exercise capacity, functional status, dyspnea, fatigue, and quality of life. Respiration. (2022) 101:593&#x2013;601. doi:&#xa0;10.1159/000522118</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000522118</ArticleId><ArticleId IdType="pmc">PMC9059007</ArticleId><ArticleId IdType="pubmed">35203084</ArticleId></ArticleIdList></Reference><Reference><Citation>Goel N, Goyal N, Nagaraja R, Kumar R. Systemic corticosteroids for management of &#x2018;long-COVID&#x2019;: an evaluation after 3 months of treatment. Monaldi Arch Chest Dis. (2021) 92. doi:&#xa0;10.4081/MONALDI.2021.1981</Citation><ArticleIdList><ArticleId IdType="doi">10.4081/MONALDI.2021.1981</ArticleId><ArticleId IdType="pubmed">34730322</ArticleId></ArticleIdList></Reference><Reference><Citation>Koc HC, Xiao J, Liu W, Li Y, Chen G. Long COVID and its management. Int J Biol Sci. (2022) 18:4768&#x2013;80. doi:&#xa0;10.7150/IJBS.75056</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/IJBS.75056</ArticleId><ArticleId IdType="pmc">PMC9305273</ArticleId><ArticleId IdType="pubmed">35874958</ArticleId></ArticleIdList></Reference><Reference><Citation>Thye AYK, Law JW-F, Tan LT-H, Pusparajah P, Ser H-L, Thurairajasingam S, et al. . Psychological symptoms in COVID-19 patients: insights into pathophysiology and risk factors of long COVID-19. Biol (Basel). (2022) 11(1):61. doi:&#xa0;10.3390/BIOLOGY11010061</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/BIOLOGY11010061</ArticleId><ArticleId IdType="pmc">PMC8773222</ArticleId><ArticleId IdType="pubmed">35053059</ArticleId></ArticleIdList></Reference><Reference><Citation>Tosato M, Calvani R, Picca A, Ciciarello F, Galluzzo V, Coelho-J&#xfa;nior HJ, et al. . Effects of l-arginine plus vitamin C supplementation on physical performance, endothelial function, and persistent fatigue in adults with long COVID: A single-blind randomized controlled trial. Nutrients. (2022) 14(23):4984. doi:&#xa0;10.3390/NU14234984</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/NU14234984</ArticleId><ArticleId IdType="pmc">PMC9738241</ArticleId><ArticleId IdType="pubmed">36501014</ArticleId></ArticleIdList></Reference><Reference><Citation>Vollbracht C, Kraft K. Oxidative stress and hyper-inflammation as major drivers of severe COVID-19 and long COVID: implications for the benefit of high-dose intravenous vitamin C. Front Pharmacol. (2022) 13:899198/BIBTEX. doi:&#xa0;10.3389/fphar.2022.899198</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2022.899198</ArticleId><ArticleId IdType="pmc">PMC9100929</ArticleId><ArticleId IdType="pubmed">35571085</ArticleId></ArticleIdList></Reference><Reference><Citation>Piazza M, Di Cicco M, Pecoraro L, Ghezzi M, Peroni D, Comberiati P. Long COVID-19 in children: from the pathogenesis to the biologically plausible roots of the syndrome. Biomolecules. (2022) 12(4):556. doi:&#xa0;10.3390/BIOM12040556</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/BIOM12040556</ArticleId><ArticleId IdType="pmc">PMC9024951</ArticleId><ArticleId IdType="pubmed">35454144</ArticleId></ArticleIdList></Reference><Reference><Citation>Plassmeyer M, Alpan O, Corley MJ, Premeaux TA, Lillard K, Coatney P, et al. . Caspases and therapeutic potential of caspase inhibitors in moderate-severe SARS-CoV-2 infection and long COVID. Allergy. (2022) 77:118&#x2013;29. doi:&#xa0;10.1111/ALL.14907</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ALL.14907</ArticleId><ArticleId IdType="pmc">PMC8222863</ArticleId><ArticleId IdType="pubmed">33993490</ArticleId></ArticleIdList></Reference><Reference><Citation>Hollifield M, Cocozza K, Calloway T, Lai J, Caicedo B, Carrick K, et al. . Improvement in long-COVID symptoms using acupuncture: A case study. Med Acupunct. (2022) 34:172&#x2013;6. doi:&#xa0;10.1089/ACU.2021.0088</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ACU.2021.0088</ArticleId><ArticleId IdType="pmc">PMC9248334</ArticleId><ArticleId IdType="pubmed">35832108</ArticleId></ArticleIdList></Reference><Reference><Citation>Satoh T, Trudler D, Oh CK, Lipton SA. Potential therapeutic use of the rosemary diterpene carnosic acid for alzheimer&#x2019;s disease, parkinson&#x2019;s disease, and long-COVID through NRF2 activation to counteract the NLRP3 inflammasome. Antioxidants (Basel). (2022) 11(1):124. doi:&#xa0;10.3390/ANTIOX11010124</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ANTIOX11010124</ArticleId><ArticleId IdType="pmc">PMC8772720</ArticleId><ArticleId IdType="pubmed">35052628</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaes AW, Go&#xeb;rtz YMJ, Van Herck M, Machado FVC, Meys R, Delbressine JM, et al. . Recovery from COVID-19: a sprint or marathon? 6-month follow-up data from online long COVID-19 support group members. ERJ Open Res. (2021) 7:00141&#x2013;2021. doi:&#xa0;10.1183/23120541.00141-2021</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00141-2021</ArticleId><ArticleId IdType="pmc">PMC8012818</ArticleId><ArticleId IdType="pubmed">34041295</ArticleId></ArticleIdList></Reference><Reference><Citation>Bateman L, Bested AC, Bonilla HF, Chheda BV, Chu L, Curtin JM, et al. . Myalgic encephalomyelitis/chronic fatigue syndrome: essentials of diagnosis and management. Mayo Clin Proc. (2021) 96:2861&#x2013;78. doi:&#xa0;10.1016/j.mayocp.2021.07.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2021.07.004</ArticleId><ArticleId IdType="pubmed">34454716</ArticleId></ArticleIdList></Reference><Reference><Citation>Hohberger B, Harrer T, Mardin C, Kruse F, Hoffmanns J, Rogge L, et al. . Case report: neutralization of autoantibodies targeting G-protein-coupled receptors improves capillary impairment and fatigue symptoms after COVID-19 infection. Front Med (Lausanne). (2021) 8:754667. doi:&#xa0;10.3389/fmed.2021.754667</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.754667</ArticleId><ArticleId IdType="pmc">PMC8637609</ArticleId><ArticleId IdType="pubmed">34869451</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Choi T, Al-Aly Z. Nirmatrelvir and the risk of post-acute sequelae of COVID-19. medRxiv. (2022). doi:&#xa0;10.1101/2022.11.03.22281783</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.11.03.22281783</ArticleId></ArticleIdList></Reference><Reference><Citation>Zubchenko S, Kril I, Nadizhko O, Matsyura O, Chopyak V. Herpesvirus infections and post-COVID-19 manifestations: a pilot observational study. Rheumatol Int. (2022) 42:1523&#x2013;30. doi:&#xa0;10.1007/s00296-022-05146-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-022-05146-9</ArticleId><ArticleId IdType="pmc">PMC9159383</ArticleId><ArticleId IdType="pubmed">35650445</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E, Venter C, Laubscher GJ, Kotze MJ, Oladejo SO, Watson LR, et al. . Prevalence of symptoms, comorbidities, fibrin amyloid microclots and platelet pathology in individuals with Long COVID/Post-Acute Sequelae of COVID-19 (PASC). Cardiovasc Diabetol. (2022) 21:148. doi:&#xa0;10.1186/s12933-022-01579-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-022-01579-5</ArticleId><ArticleId IdType="pmc">PMC9356426</ArticleId><ArticleId IdType="pubmed">35933347</ArticleId></ArticleIdList></Reference><Reference><Citation>
A new treatment for Long Covid (2021). The ME Association. Available online at: https://meassociation.org.uk/2021/10/a-new-treatment-for-long-covid/ (Accessed Aug. 21, 2023).</Citation></Reference><Reference><Citation>Wood E, Hall KH, Tate W. Role of mitochondria, oxidative stress and the response to antioxidants in myalgic encephalomyelitis/chronic fatigue syndrome: A possible approach to SARS-CoV-2 &#x2018;long-haulers. Chronic Dis Transl Med. (2021) 7:14&#x2013;26. doi:&#xa0;10.1016/j.cdtm.2020.11.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cdtm.2020.11.002</ArticleId><ArticleId IdType="pmc">PMC7680046</ArticleId><ArticleId IdType="pubmed">33251031</ArticleId></ArticleIdList></Reference><Reference><Citation>The C-MORE/PHOSP-COVID Collaborative Group . &#x201c;Multiorgan MRI findings after hospitalization with COVID-19 in the UK (C-MORE): a prospective, multicentre, observational cohort study. Lancet. (2022) 11:1003&#x2013;19. doi:&#xa0;10.1016/S2213-2600(23)00262-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(23)00262-X</ArticleId><ArticleId IdType="pmc">PMC7615263</ArticleId><ArticleId IdType="pubmed">37748493</ArticleId></ArticleIdList></Reference><Reference><Citation>Aiyegbusi OL, Hughes SE, Turner G, Cruz Rivera S, McMullan C, et al. . Symptoms, complications and management of long COVID: a review. J R Soc Med. (2021) 114:428&#x2013;42. doi:&#xa0;10.1177/01410768211032850/ASSET/IMAGES/LARGE/10.1177_01410768211032850-FIG3.JPEG</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/01410768211032850/ASSET/IMAGES/LARGE/10.1177_01410768211032850-FIG3.JPEG</ArticleId><ArticleId IdType="pmc">PMC8450986</ArticleId><ArticleId IdType="pubmed">34265229</ArticleId></ArticleIdList></Reference><Reference><Citation>Dani M, Dirksen A, Taraborrelli P, Torocastro M, Panagopoulos D, Sutton R, et al. . Autonomic dysfunction in &#x2018;long COVID&#x2019;: rationale, physiology and management strategies. Clin Med. (2021) 21:e63. doi:&#xa0;10.7861/CLINMED.2020-0896</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/CLINMED.2020-0896</ArticleId><ArticleId IdType="pmc">PMC7850225</ArticleId><ArticleId IdType="pubmed">33243837</ArticleId></ArticleIdList></Reference><Reference><Citation>Nurek M, Rayner C, Freyer A, Taylor S, J&#xe4;rte L, MacDermott N, et al. . Recommendations for the recognition, diagnosis, and management of long COVID: a Delphi study. Br J Gen Pract. (2021) 71:E815&#x2013;25. doi:&#xa0;10.3399/BJGP.2021.0265</Citation><ArticleIdList><ArticleId IdType="doi">10.3399/BJGP.2021.0265</ArticleId><ArticleId IdType="pmc">PMC8510689</ArticleId><ArticleId IdType="pubmed">34607799</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown DA, O&#x2019;Brien KK. Conceptualizing Long COVID as an episodic health condition. BMJ Glob Health. (2021) 6:e007004. doi:&#xa0;10.1136/BMJGH-2021-007004</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/BMJGH-2021-007004</ArticleId><ArticleId IdType="pmc">PMC8460526</ArticleId><ArticleId IdType="pubmed">34551971</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolf S, Zechmeister-Koss I, Erd&#xf6;s J. Possible long COVID healthcare pathways: a scoping review. BMC Health Serv Res. (2022) 22:1076. doi:&#xa0;10.1186/S12913-022-08384-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/S12913-022-08384-6</ArticleId><ArticleId IdType="pmc">PMC9396575</ArticleId><ArticleId IdType="pubmed">35999605</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo WR, Wu XM, Wang W, Yu JL, Chen QQ, Zhou Q, et al. . Novel coronavirus mutations: Vaccine development and challenges. Microb Pathog. (2022) 173:105828. doi:&#xa0;10.1016/J.MICPATH.2022.105828</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.MICPATH.2022.105828</ArticleId><ArticleId IdType="pmc">PMC9561474</ArticleId><ArticleId IdType="pubmed">36243381</ArticleId></ArticleIdList></Reference><Reference><Citation>
SARS-coV-2 variant classifications and definitions. Available online at: https://www.cdc.gov/coronavirus/2019-ncov/variants/variant-classifications.html (Accessed Sep. 13, 2023).</Citation></Reference><Reference><Citation>Fatemeh M, Zelikovsky A, Mangul S, Chowell G, Skums P, et al. . Community structure and temporal dynamics of SARS-CoV-2 epistatic network allows for early detection of emerging variants with altered phenotypes. bioRxyv. (2023). doi:&#xa0;10.1101/2023.04.02.535277</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2023.04.02.535277</ArticleId></ArticleIdList></Reference><Reference><Citation>
Will BA.2.86 (&#x2018;Pirola&#x2019;), the new coronavirus variant, increase COVID-19 cases? &gt; news, in: Yale medicine. Available online at: https://www.yalemedicine.org/news/new-covid-variant-ba286-pirola (Accessed Sep. 13, 2023).</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>